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Preface 
Informed consent in healthcare has evolved markedly throughout history through 
legislative rulings, regulations, and research.  Significant recent evolution has occurred 
in surgical, medical and nursing professions for which there exists a wealth of research. 
This disciplinary experience and knowledge has also altered the way informed consent 
is now understood and obtained within other allied primary health professions, such as 
osteopathy.  However, unlike these professions, there is limited research into informed 
consent within an osteopathy context.  
 
The aim of this study is to investigate the nature of patients’ lived experience of 
informed consent within an osteopathic consultation. Participants of this study were 
interviewed and their responses analysed, using an Interpretative Phenomenological 
Interpretation methodology, in order to gain a depth of knowledge about this lived 
experience. This has the potential to provide an insight into how patients perceive the 
informed consent process. The information from this research could help osteopaths 
can create an environment rich in information exchange, patient autonomy and 
mutually agreed treatment processes.  
 
This thesis is presented in four sections. Section one is a literature review about 
communication, information exchange, and informed consent in healthcare, with an 
emphasis on New Zealand and osteopathic contexts. Section two outlines a 
comprehensive description of the phenomenological methodology and the application 
of this approach to the research methods. Section three contains a manuscript that is 
formatted in accordance with the International Journal of Osteopathic Medicine (IJOM) 
submission requirements (see Appendix K). This manuscript reports the investigation 
into the patient experience of informed consent in osteopathy and includes the results 
and a discussion. Section four is the Appendices which contains supplementary 
documentation such as ethical approval, participant information and consent forms, and 
examples of the data analysis process.
  
 
 
 
 
Section 1: Literature Review 
  
 7 
Introduction 
Healthcare practitioners have an ethical, administrative, and legal obligation to provide 
the information which allows patients to give informed consent (1-4). Yet, a definition 
of “adequate” informed consent, especially in applied clinical settings, continues to be a 
point of contention among medical disciplines (2, 5). It is generally viewed as the 
patient giving their permission for the practitioner to perform mutually agreed upon 
treatments after understanding risks and benefits of possible treatment options and 
therapeutic interventions (6, 7). In its narrow and self-interested sense, gaining consent 
may be construed by practitioners as mitigating their own risk in the face of adverse 
events (8). However, the ethical duty of practitioners stretches beyond professional 
self-protection or preservation. Broadening the view of consent beyond a legal 
requirement, to one that encourages the exchange of information to inform patients, 
creates the basis for patient autonomy, empowerment, therapeutic engagement and 
successful treatment outcomes (3, 4, 8, 9).  
 
History of Informed Consent 
Historically, consent was described as a patient’s “right to determine what shall be done 
with his (sic) body” (10). The evolution of consent though, has become more complex 
over time. Conceptually, it is the patient providing their consent for the practitioner to 
treat after a mutual understanding of the risks and benefits, and alternative therapeutic 
interventions, is reached (2, 6, 7, 11, 12). However, within this general view, a 
significant point of contention is recognizing how true informed consent is best 
obtained within a clinical setting. 
 
Within a New Zealand context, the evolution of informed consent is especially pertinent. 
In 1988, The Cartwright Inquiry (13) was instrumental in the move of New Zealand 
practitioners and researchers towards the inclusion of informed consent processes in 
their work’s ethical protocols. The inquiry began after Professor Herbert Green 
performed a longitudinal experiment on 948 women undergoing gynaecological 
examinations. The experiment involved intentionally undertreating cervical cancer, 
without any form of informed consent from the participants (13). The Cartwright 
Inquiry and subsequent report made detailed recommendations about improving 
communication and informed consent practices. The main elements recommended in 
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the report included the right of patients to personal autonomy, receiving adequate 
information about treatments, risks, and benefits, providing multiple appropriate 
treatment options, and the choice to decline proposed treatments, or withdraw or 
decline treatments being administered (13-15).  The report and its recommendations 
triggered widespread changes to informed consent processes in a wide variety of 
practitioner and research-oriented environments (15) and have framed the subsequent 
legislative reforms and regulations around informed consent with healthcare 
practitioners across New Zealand (14).  
 
Communication and Informed Consent 
Communication is defined as “the process of creating shared understanding” (16). In a 
clinical setting, it consists of verbal and non-verbal cues acting dynamically to reach this 
shared understanding (17-20). Research has noted that non-verbal communication has 
directly affected the quality of patient-centred communication and levels of patient 
satisfaction (17-20). Non-verbal cues such as images, colours, body language, eye 
contact, and environment work dynamically with verbal cues to mould the patient’s 
experiences of informed consent messages (20-22) and influence the extent to which 
the patient is engaged and participating actively in clinical discussions (17). Nonverbal 
communication is therefore a key element of communicating and understanding the 
informed consent process within a wider successful clinician-patient consultation 
experience.  
 
Relevance to Osteopathy Treatment 
As osteopathy is a primary healthcare profession regularly dealing with patients in a 
vulnerable state, it is inevitable that concerns and complaints will arise. A two-year 
exploratory study undertaken by Carnes (23) reviewed all reported concerns and 
complaints about osteopaths in the United Kingdom. A significant portion of concerns 
was categorised as ‘conduct of osteopath’. These concerns mainly related to 
inappropriate or ineffective communication, and failure to gain valid consent. A second 
significant category of concerns related to perceived inappropriate or unjustified 
treatments. It is widely recognised that the effects of consent malpractice can result in 
patient harm and legal action (14, 15, 24). This is especially pertinent to osteopathy and 
manual therapy as any touching of another human being that is unauthorised or 
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unconsented is considered assault in the eyes of the law (25). The medico-legal 
implications for osteopaths also extend beyond this to the risk of professional 
negligence. Health practitioners are exposed to accusations of negligent behaviour if 
they fail to completely advise the patient of inherent risks, efficacy, and nature of the 
proposed treatment (25). The findings from Carnes’ (23) study re-affirm that effective 
communication with patients and gaining informed consent should always be a 
professional priority and area of continual development and refinement, to ensure 
consistently high standards of ethical practice. 
 
The Cartwright Inquiry has also underpinned informed consent protocols in New 
Zealand osteopathic settings. Obtaining informed consent is a requirement of the 
osteopathic practice standards enforced by the Osteopathic Council of New Zealand 
(26). However, despite this national standard and continuing professional guidance, 
practitioner compliance to these standards needs on-going support. Recent cases of 
sub-par informed consent processes in osteopathy were initiated by patient complaints 
to the New Zealand Health and Disability Commissioner (27, 28). The investigations 
into these complaints concluded that clear communication of the patient’s diagnosis, 
and risks and benefits of treatment were inadequate and affected carers as well as the 
patient (28). These investigations highlight the need for improved professional 
guidance and practice, which may emerge from greater understandings of the patient 
experience of granting informed consent. 
 
Giving Information  
Informed consent is implicitly related to practitioners giving information about clinical 
reasoning (5, 8, 29). Yet, the consent processes patients will experience in their 
consultation continually risk being de-prioritised, condensed into overly-simplistic 
forms, or fully omitted (7, 29) despite the post-Cartwright recommended pathways 
towards ethically sound practice and research. Inadequate or ineffective 
communication reduces the consent process for treatment to levels where the 
practitioner assumes or infers consent, or the patient implies their consent through 
attendance and passive participation. In either situation little is strategically done to 
gather the patients’ valid and active informed consent (4, 30).  
 
 10 
It is commonly recognized that patients remember approximately half of the 
information disclosed throughout the informed consent process (31-35). This varies 
depending on the effects of age, education, cognitive function, and anxiety about their 
presenting complaint (12, 33, 35, 36). A combination of good verbal plain language 
explanations, visual aids and models, and audience appropriate written information is 
regarded as highly preferable by patients (37-39). Personalised multimedia resources 
and structuring information into concise summaries of essential information could 
increase information retention (40-42) as it overcomes the problem of generically 
written information contributing to reduced information retention (40-43). Arnold et 
al., (43) suggests that making informed consent processes patient-specific and an 
educational opportunity, enables the patient to participate more actively in their care 
because there is a greater depth to their understanding.  
 
On the other hand, some studies have shown that providing comprehensive information 
around informed consent in combined oral, written, and video formats produce mixed 
effects on patient anxiety, comprehension, or satisfaction. Some researchers suggest 
that the form of presentation is clinically insignificant or has no impact on these factors 
(44, 45), while others (7, 12, 29, 37, 39, 46-48) challenge this view. Over 75% of 
patients in Daniels & Vogel’s (37) osteopathic study about what, when, and how 
information should be provided to patients, believed that written consent forms 
inadequately serve the purpose of informed consent, preferring verbal consent 
processes instead. A further aspect complicating the situation is the practitioner’s 
preferred mode of communication. While these findings show patients endorse the 
process of informed consent and highly rate information about current diagnosis and 
treatment risks (2, 29, 39, 46, 49-51), that endorsement is mediated by the verbal, 
visual and written modes of communication preferred by the practitioner (37).  That is, 
practitioners can use conversation to successfully gain consent, however patients may 
gain more from a combination of oral, visual, and written resources.  
 
Benefits of Informed Consent 
There are a number of advantages for both patient and practitioner from gaining 
informed consent that leads to enhanced clinical experiences and improved therapeutic 
relationships. Patients who are informed have more opportunities to actively 
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participate and follow treatment plans because they reach common understandings 
with their clinician through the consent processes (46, 52, 53). This can include 
information about their illness, prognosis, and treatment options. Improved therapeutic 
relationship and effective communication act reflexively upon one another, which can 
strengthen patient trust and orientate the consultation towards a patient-centred 
approach (4, 29, 46, 48, 53, 54). Practicing consistent informed consent benefits the 
patient, the practitioner, and the relationship between the two (29, 53, 55). 
 
Risks associated with Manual Therapy 
Although informed consent in osteopathy is required, and the benefits from consistently 
practising it have been evidenced and are significant, there are few studies about 
informed consent in osteopathy that focus on the experience of the patient or approach 
the issue from a patient’s perspective. A small pilot study in the United Kingdom used 
focus groups of patients and osteopaths to discuss the communication of risks, benefits 
and shared decision-making in an osteopathic setting (6). A small part of this research 
asked patients about their perception of information about risk. They found it odd that 
osteopaths were expected to provide information about treatment risks when their 
General Practitioner did not routinely discuss the risks of prescribed medication. Some 
respondents mentioned that no one discussed risks or, if they were mentioned, they 
took no notice anyway. A survey of Australian physiotherapists found that only 33% of 
respondents consistently sought informed consent for cervical manipulations (56). 
Spinal manipulations have been linked to mild adverse reactions such as headaches, 
discomfort, and fatigue (57). There have been causal links to more severe adverse 
reactions such as vertebral artery dissections (58), disc herniations, strokes, fractures, 
and even death (57, 59, 60). There is significant debate about the frequency of these 
more severe occurrences however because, as the literature notes there is a lack of 
inter-professional reporting or under-reporting of incidents (61-64). Osteopaths, 
however, should be wary about these treatment reaction risks. It is interesting to note 
that patients felt it was necessary to be informed about the likely risks and benefits of 
their possible treatment options and to share the decision making, leading the patient to 
be more active and engaged in the consultation (3, 6, 29).  
 
Implied and Tacit Consent 
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Seeking and delivering consent in serial consultations is potentially troublesome. 
Repeatedly following ethical procedures for consensual treatment can seem 
monotonous or unnecessary for a patient who visits an osteopath regularly for the same 
treatment (37). In this scenario, the patient may appear to be tacitly placing their trust 
in the practitioners’ choice of treatment. Research has identified the patients’ conduct, 
conversational statements, following instructions, the absence of dissenting, or their 
voluntary regular attendance at a clinic as forms of implied or tacit consent (25, 29, 65). 
Also, both parties may feel that making a free, voluntary, and declared informed 
decision is unnecessary, beyond the first consultation as the practitioner is assumed to 
be acting in the patient’s best interest (3, 66).  However, in the case of serial treatments, 
where the patient’s circumstances or management changes, the practitioner is obliged 
to repeat the informed consent process and discuss inherent risks and benefits of 
different treatment plans (32). In general, even if the patient thinks it is unnecessary or 
tedious (24, 29), obtaining on-going consent over time for numerous treatments is an 
ethical imperative, a legal obligation and a vital competency that should be consistently 
sustained for practitioners (26, 65). 
 
Conclusion 
The literature review has shown that the process of communicating informed consent 
and indicating patient preference have been topics of research for many years and have 
largely focused on conceptual ethico-legal and litigious contexts within the context of 
doctors, surgeries, and hospitals (7, 12, 24, 43). It has also revealed a number of 
contentious issues with respect to how information about treatment information, 
including the use of purposed and personalized multimedia options, should be 
presented, and how regularly practitioners should actively seek consent from the 
regular patients. Current investigations in an osteopathic context, for example, include 
the use of a patient information leaflet (6). There is a gap in the research that analyses 
the subjective perceptual factors that constitute a patient’s lived experiences of 
informed consent beyond the preferred process of information exchange (37). The aim 
of this study is to initiate an investigation that has the potential to provide new insights 
into patient–practitioner communication using semi-structured interviews and 
phenomenological analysis methodology. By looking at consent through the patient 
experience, the study hopes to identify adaptations and adjustments practitioners could 
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implement to improve patient autonomy, ensure complete patient and practitioner 
safety, comfort and trust and reduce the number of complaints or concerns made 
against osteopaths. 
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Note: This section provides a comprehensive review of the methods reported in 
Section 3 (Manuscript). Some of this content overlaps with Section 3, but is 
provided to give a more comprehensive overview.  
 21 
Methodology 
The following chapter describes the research methodology and methods used to explore 
patients’ experiences of informed consent in osteopathic consultations. It briefly 
describes the two dominant research paradigms and then explains in more detail the 
rationale for choosing Interpretative Phenomenological Analysis (IPA) with which to 
design, conduct the research and subsequent data analysis. 
 
The study of informed consent in osteopathy has been negligible and therefore there is 
limited understanding of the patient experience of informed consent in an osteopathic 
setting. In order to gain an insight into the patient experience of informed consent, 1 
osteopathic practitioner and 6 patients were investigated using interpretative 
phenomenological inquiry.  
 
Qualitative Research 
The aim of research is to describe, explain, or answer specific research questions. Two 
dominant paradigms – quantitative and qualitative – shape the methodological 
decisions contemporary researchers make. These paradigms have distinctive 
philosophical underpinnings (1). Qualitative research aims to achieve a close-up, multi-
faceted view of a single phenomena or experience (3). The data collected in a qualitative 
paradigm is rich in personal emotion, expression, and detail to the point of saturation 
(1). Qualitative research does not aim to provide generalisable results across the 
population but focuses on deeply exploring a single phenomena or experience instead. 
Researcher biases and assumptions are made clear and suspended to allow for 
complete immersion and engagement to understand the data collected (1, 3). The 
results of a qualitative study provide the foundation upon further knowledge can be 
built upon and, in clinical settings, may contribute toward a more patient-focused 
practice, sensitive to their needs and experiences (3). It is within this qualitative 
paradigm that this phenomenological study of the patient experience of informed 
consent in an osteopathic setting in contextualised.  
Interpretative Phenomenological Analysis 
For this exploratory study, Interpretative Phenomenology Analysis (IPA) was chosen to 
answer the research question ‘What are the experiences of informed consent in a New 
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Zealand clinical osteopathic consultation for six patients?’. IPA was chosen because it 
aims to make sense of another person’s interpretation of a given phenomena in a given 
context (4). It allows the researcher to not only create a relevant, detailed coding 
system but also interpret the meaning of the themes and claims that are extrapolated 
from the data. IPA captures not only the participants’ experience, but also explores the 
meanings assigned to the experiences and describes how the researcher interprets 
these experiences (5-7). IPA has been successful in earlier osteopathic research 
contexts (7) including investigating the views and experiences of informed consent (5, 
6). For this study, IPA aligns methodologically with the aim of the researcher to 
understand the patient’s experience and interpretation of informed consent and how to 
make sense of these. The researcher is simultaneously a trainee osteopath and 
osteopathic patient. These dual roles have developed some preconceptions about 
informed consent processes in osteopathy. These preconceptions include the 
importance of informed consent as an ethical and legal requirement. All preconception 
were identified in full and suspended in order to focus on the experiences of the 
research participants.  
 
Phenomenology 
Where little is known about a phenomenon, phenomenological inquiry gives the 
researcher an opportunity to seek an understanding of the phenomenon  
(8, 9). Phenomenology questions the nature of phenomena (9) and guides the 
interpretative process towards mean-making (8) (9). As a research approach it is 
distinguished by three philosophical features: a belief in the importance of subjective 
consciousness; that consciousness is active and bestows meaning; and that knowledge 
can be gained by understanding the essential structures of consciousness (10).  
Therefore, phenomenological inquiry is a valuable tool for gaining an understanding of 
the human experience. Specifically, the researcher conducted individual semi-
structured interviews of six patients to gain an understanding of their experiential 
perceptions of the informed consent process in osteopathy. Interviews allowed the 
inquiry to capture and compare the participants’ experiences as naturalistic phenomena 
to a depth and richness sufficient to inform a methodologically sound and verifiable 
analysis (11). 
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Hermeneutics 
The work of Schleiermacher, Heidegger, and Gadamer (12) primarily inform our 
understanding of hermeneutics, the second major influence on IPA. Essentially, 
hermeneutics is premised on the view that reality is socially constructed and focuses on 
interpreting social interaction and language. Hermeneutics is concerned more with the 
meanings of a phenomenon than the phenomenon itself.  In the qualitative sciences, 
hermeneutics is about meanings and intentions: capturing the meanings of situated 
human interaction and revealing the underlying intentions of these interactions. It 
involves the analysis of meaning in a social context (10). Importantly, hermeneutic 
research explicitly acknowledges the researcher’s subjectivity in their attempts to 
examine phenomena, interpret data, and make analytical sense of the participant’s 
world (4) and is therefore an integral part of the IPA methodology,   
 
Idiography 
The third major influence of IPA is idiography. This emphasizes explaining and 
understanding the unique and the particular of individual cases, in order to understand 
wider principles of individual behaviour. In other words, idiographic research focuses 
on a particular subjective, relativistic social world rather than a prescribed, ordered and 
external reality (10). To achieve this, the researcher positions participants in a 
particular context and explores their particular individual experiences, seeking to 
uncover how each participant represents and conceptualises their personal experience 
of the context. This study follows the key principles of idiographic research by 
thoroughly examining the particulars of each case individually before moving on to 
interpreting behavioural patterns of the group. Idiographically researching the patients’ 
lived experience of informed consent in osteopathic consultations has the potential to 
reveal, at their deepest level, patterns of behaviour that may be hidden, or present quite 
differently at surface levels (12).  
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Methods 
This section discusses project details including participant recruitment and ethical 
considerations. Data collection, data management, and data analysis are discussed in 
the conclusion of this sub-section.  
 
Sample Selection and Recruitment 
The involvement of both an osteopath and patients required two separate recruitment 
processes for this research investigation. The sample selection and recruitment 
methods were:  
1. Purposive sampling was used to find an osteopath who values informed consent 
as a tool to improve collaboration between practitioner and patient. The 
researcher asked registered, practising osteopaths and the Osteopathic Council 
of New Zealand if they knew of someone that matched the description. All 
recommendations were approached and their eligibility was determined. 
Following recruitment, the researcher provided a detailed explanation of the 
research investigation, which included a description of what was entailed and 
the commitment they were making (see Appendix A). A signed written consent 
form was completed before data collection began (see Appendix B).  
 
2. The researcher recruited a total of six patients using convenience sampling 
through telephone conversations from the database of a single tertiary 
osteopathic teaching clinic, where the researcher worked, in New Zealand. The 
researcher discussed the research process and eligibility criteria with interested 
candidates. An appointment time was established where participants were 
briefed further with a written information sheet and given the opportunity to 
have questions answered by the researcher (see Appendix C). Participants then 
gave written consent to the researcher and were enrolled in the study (see 
Appendix D), at which stage they were introduced to the osteopath. 
 
Inclusion, Exclusion and Withdrawal Criteria 
Osteopath Criteria 
Inclusion Criteria: 
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• The osteopathic practitioner must be registered in New Zealand and hold an 
Annual Practising Certificate. 
• The osteopathic practitioner must understand the research process and consent 
to the audio recording of their consent in a clinical consultation. 
• The osteopathic practitioner must value informed consent as a tool to improve 
collaboration between practitioner and patient.  
• The osteopathic practitioner must collaborate with the creation of a brief guided 
written reflection and complete one at the conclusion of each consultation with 
participating patients.  
• The osteopathic practitioner agrees to collaborate with the researcher to create a 
structured checklist of items that are required for establishing informed consent. 
This checklist must be used in the studied consultations. 
 
Withdrawal Criteria 
• The osteopath may withdraw their own data (six recorded consultations and 
guided written reflections) from the study up to five working days after their 
final consultation and accompanied recording and reflection is completed. 
 
Patient Criteria 
Inclusion Criteria: 
• Six patients of any gender above the age of 16. The age of consent criteria has 
been put in place to ensure that informed consent for the research can be 
provided as an adult in New Zealand. 
• The patients must understand the research process and be able to give informed 
consent to voice recording throughout the consultation and interview. 
 
Exclusion Criteria: 
• Any friend or relative of the osteopath who treats them, or the researcher. 
• A returning or regular patient for the osteopath. 
• Participants who are unable to provide their consent in order to participate. 
• Participants who do not consent to, or withdraw their consent for, audio 
recordings of the interviews. 
• Participants who do not meet the inclusion criteria. 
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• Participants who have red flags including sudden onset of a severe headache, 
vomiting, disturbed consciousness, severe and debilitating pain.   
 
Withdrawal Criteria: 
• All patient participants may withdraw their interview data and involvement 
from the study up to five working days after their recorded consultation and 
interview. 
 
Ethical Considerations 
The research was granted ethical approval by the Unitec Research Ethics Committee, 
Approval Number: 2016:1048 (see Appendix E). The areas of ethical considerations are 
outlined below:  
 
Informed consent  
Prior to data collection, a written informed consent was obtained from all participants 
in the research. The consent form outlined the research process and intended use of the 
collected data. The contents of the written consent form was verbalised to each 
participant to ensure complete comprehension. 
 
Confidentiality  
Each patient participant was assigned a number throughout the transcription process 
and research to protect their identity and information. The osteopath’s name or location 
was not mentioned throughout research process to avoid a breach of confidentiality. An 
external transcriber, with no association to the research project or participants, was 
used to transcribe the interviews. A Transcribers Confidentiality Agreement (see 
Appendix F) was signed prior to transcription. 
 
Data Security 
All data were stored in an encrypted file on the researcher’s personal computer and 
flash-drive. All original files were immediately disposed of. The only people who had 
access to this information was the researcher and supervisors, upon request. All data 
will be retained for 10 years following the date of the consultation and securely stored 
in a locked filing cabinet at the researcher’s residence. During this period, only the 
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researcher and supervisors will have access unless express permission is granted from 
the involved participants. Following this, the data will be destroyed to ensure 
confidentiality is maintained. 
 
Personal Psychosocial or Emotional Harm 
Because informed consent can be considered a sensitive topic, the possibility of 
psychosocial or emotional harm was outlined when ethical approval for the study was 
sought. A subsequent action plan was made to offer details of a free counselling service. 
There were no instances where the action plan had to be carried out. The participants 
were provided with the contact details of the researcher and supervisor in the event of 
any follow-up questions or complaints.  
 
Data Collection 
Before data collection began, the osteopath collaborated with the researcher to create a 
checklist of the components of consent that needed to be covered in each consultation 
to ensure that the studied phenomenon was similar for each participant (see Appendix 
G). Three methods were used to collect data. Firstly, the studied consultations and the 
informed consent processes were recorded in their entirety. Secondly, the osteopath 
wrote a short, guided reflection following each studied consultation. Thirdly, semi-
structured face-to-face interviews were used to gather the patient participants’ 
experiences of the consultation.  
 
Guided Written Reflections 
After each consultation with a participating patient, the osteopath completed a guided 
reflection (see Appendix H). The reflection had open-ended questions for the osteopath 
to provide as much or as little information as they like. The questions were mutually 
agreed upon and created with both the osteopath and researcher prior to data 
collection. The guiding questions allowed for consistency between reflections. The 
opportunity was given to the osteopath to add or remove any information in the 
reflection up to 48 hours after the consultation. The reflection was estimated to take 10 
minutes to complete and provided an insight into how the osteopath believed the 
informed consent process went. They also aided the researcher in contextualising the 
phenomenon by understanding the osteopath’s intentions of what consent was gained 
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for. However, these reflections were not included in the analysed data because they did 
not provide further insight on the patient experience. 
 
Semi-Structured Interviews 
Individual semi-structured interviews were held with the six patient participants. Each 
interview lasted approximately 30 minutes in length; however, there was flexibility in 
the length depending on the participants’ needs. The interviews took place, over the 
telephone, within 48 hours following the osteopathic consultation. Interviewer bias and 
influence was limited by using clean language and no leading questions (13). 
Participants were allowed to answer the questions with as much or as little information 
as they wanted. An interview guide outlined the process of the interviews and topics of 
questions asked (see Appendix I).  
 
The data collection method of semi-structured interviews with a small group of 
participants who have a certain experience in common with each other is suitable for 
IPA (14). This common experience in the proposed research is the process of 
establishing informed consent by the same osteopath. The interviews were approached 
in a curious and facilitative manner to allow the richness of accounts consistent with 
phenomenological inquiry (9). As mentioned in the background literature, there have 
been no studies similar to the investigation proposed. Therefore no pre-existing 
theories will be used and assumptions will be avoided to generate the codes or themes 
when analysing the data. This is ideal as IPA explores topics where little is known (14).  
 
Data Transcription 
For convenience, an external party was paid to type transcripts of each interview and 
consultation. The transcriber completed a confidentiality agreement. The researcher 
listened to each recording while checking what the transcriptionist wrote to check for 
accuracy in the transcript. Patient participants were asked to check their interview 
transcript immediately afterwards to see whether they wish to add or delete anything. 
No participants used this opportunity. 
 
Data Analysis 
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Smith, Flowers (12) outline of IPA guided the data analysis and interpretation process 
of the interviews:  
1. Reading and re-reading  
2. Initial noting  
3. Developing emergent themes  
4. Searching for connections across emergent themes  
5. Moving on to the next case  
6. Looking for patterns across cases.  
 
Data analysis and interpretation aimed to consider the participants’ experiences and 
their attempts to make sense of these experiences. 
 
To assist in the final step of data analysis across all cases, an electronically built mind 
map was created using the website Debategraph. The map was created by the 
researcher applying thought to the type and strength of relationship between each code, 
from the researcher applying subjective meaning to the participants’ perspectives. 
Debategraph used this coding to create mindmaps, which represented of the analysed 
data (see Appendix J). This rigorous analysis of the intricacies and connections between 
the themes were reviewed to ensure they reflected the researcher’s understanding of 
the collected data. 
 
The last step was to categorise and name the final themes. Secondary thematic analysis 
was undertaken at a meeting of the researcher and one of the supervisors team. In this 
phase, the initial themes were defined, refined and renamed to determine the story of 
each theme and its link to data. An informative name for each theme that resonated 
with the researcher’s experiences interviewing the participant was added. This naming 
process also enlisted the help of a patient safety and quality specialist at a local hospital 
to bring an external and expert eye to the data and therefore enhance the face validity 
and credibility of the names assigned to themes (15, 16). 
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ABSTRACT 
 
More Than Words: An Investigation into the patient experience of informed 
consent in Osteopathy 
Medical informed consent is described as permission to perform mutually agreed upon 
examination and treatment after understanding the risks and benefits of multiple 
options. The informed consent process is at the heart of patient centred care and ethical 
practice in all health professions, yet there is a limited research base about patients' 
lived experience of informed consent in an osteopathic context. Using semi-structured 
interviews, this study explored how six patients experience the informed consent 
process in a single New Zealand osteopathic clinical setting. Interpretative 
Phenomenological Analysis (IPA) was used to analyse these experiences. The results 
show that information exchange and active patient engagement play significant roles. 
The patients in this study have little recollection of an initial and explicit consent 
process but instead, describe the ongoing process of consent as their treatment 
progresses. Information from this research can be used to help osteopaths understand 
the patient experience of consent which could lead a greater collaboration between 
patient and practitioner.  
 
Keywords: Consent, informed, osteopath, clinical, information exchange, active 
engagement  
 35 
INTRODUCTION 
Communication of treatment pathways, and of their associated risks and benefits in 
order to obtain truly informed consent is a key feature of ethical health professional 
practice and an administrative and legal obligation for healthcare practitioners (1-4).  
Yet, a definition of “adequate” informed consent, especially in applied clinical settings, 
continues to be a point of contention among health practitioners (2, 5). Historically, 
consent was described as a patient’s “right to determine what shall be done with his 
body” (6). In a more modern context, it has become more complex and nuanced (4). 
Conceptually, it is generally viewed as the patient giving their permission for the 
practitioner to perform mutually agreed upon treatments after understanding risks and 
benefits of possible treatment options and therapeutic interventions (2, 4, 7-10). A 
significant point of interest is recognising when and how consent is given or retracted 
within a clinical setting. 
 
Although informed consent for osteopathic treatment is required and significantly 
rewarding for the therapeutic relationship (11), sub-par informed consent continues to 
be a significant contributor to patient complaints both internationally and within New 
Zealand (12-14). The investigations of complaints typically note that clear 
communication of the patient’s diagnosis, and risks and benefits of treatment, were 
lacking. The quality of practitioner communication directly affects patients’ decisions to 
give or withdraw their consent (5, 15, 16). While in areas, such as medicine, consent is a 
process driven by legislative and administrative protocol, patient education, and the 
explicit signing of a consent form (2, 17); in osteopathy consent procedures vary 
between practitioners and are often verbal or indirectly communicated within the 
course of a conversation. This highlights a need for improved practitioner 
understanding about how to interpret those unspoken forms of communication that 
may signal consent or otherwise. A greater understanding of the patient experience of 
granting informed consent may provide guidance for practitioners about the informed 
consent process. 
 
Research into informed consent has been extensively conducted within the context of 
general practitioners and hospitals (4). However, there have been few investigations 
within the context of osteopathy. Current investigations only extend as far as 
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ascertaining the usefulness of a patient information leaflet (7) and preferred process of 
information exchange (18). Findings from these studies suggest that patients felt it was 
necessary to be informed about their possible treatment options and to share the 
decision making; however it can seem monotonous or unnecessary for a patient who 
visits an osteopath regularly for the same treatment. The patients’ lived experience of 
informed consent within an osteopathic setting has yet to be investigated. The aim of 
this study is to begin this investigation using semi-structured interviews and 
phenomenological analysis methodology. 
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METHODOLOGY AND METHODS 
Study design 
A qualitative research method of semi-structured interviews was used to investigate the 
patients’ lived experience of informed consent in their osteopathic treatments in New 
Zealand. Interviews provide an account of an experience that is rich in personal 
emotion, expression, and detail (19). A rigorous analysis of the data was done using an 
Interpretative Phenomenological Analysis (IPA) framework. IPA aims to understand 
and make sense of another person’s interpretation of a given phenomena in a given 
context (20). IPA was used in this study to capture not only the participant’s experience, 
but also to allow exploration of the meanings assigned to the experiences and the 
researcher's interpretations (21-23). This study follows the reporting requirements 
outlined in the consolidated criteria for reporting qualitative research (COREQ) (24) – 
see supplementary material. 
 
Participants 
Participants were an osteopath and 6 patients who had received treatment at an 
Osteopathy teaching clinic in New Zealand in the past.  
 
Inclusion criteria 
To be included in this study, the osteopath was required to hold active registration with 
the Osteopathic Council of New Zealand, and a current Annual Practising Certificate. 
 
For inclusion, patients were required to meet the following criteria:  
(1) be aged above 16 years to ensure that informed consent for the research can 
be provided as an adult in New Zealand;  
(2) had not received treatment from the participating osteopath in the past; 
(3) exhibited no ‘red flags’ at the time of consultation, including sudden onset of 
a severe headache, vomiting, disturbed consciousness, severe and debilitating 
pain. 
 
Recruitment 
Purposive sampling was used to find an osteopath who values informed consent as a 
tool to improve collaboration between practitioner and patient.   
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After eligibility was determined, the osteopath received a detailed explanation of the 
research investigation, which included a description of what was involved and the 
commitment they were making. A signed written consent form was completed by the 
osteopath before data collection began. 
 
The researcher recruited a total of six patients through telephone conversations from 
the database of a single tertiary teaching clinic in New Zealand, where the researcher 
worked. Interested candidates were formally interviewed to discuss the research 
process and eligibility criteria. The first 6 eligible candidates were accepted. An 
appointment time was established where participants were further briefed with an 
information sheet and given the opportunity to have questions answered. Participants 
then gave written consent for the research and were enrolled in the study, at which 
stage they were introduced to the osteopath. 
 
Ethical considerations 
The study was approved by the Unitec Research Ethics Committee (UREC Approval No: 
2016:1048). All participants gave written informed consent for their involvement in the 
research, prior to the consultations commencing. Participant privacy is protected by the 
use of a secure location to store physical material, and password encryption for 
electronic data. All participants were offered the opportunity to withdraw their 
involvement and their interview data, from the study up to five working days after their 
recorded consultation. 
 
Procedures 
The procedure to undertake this research investigation involved: (1) the patient and 
osteopath were introduced to one another and directed to the consultation room by the 
researcher; (2) the researcher turned on the audio recorder and left the room; (3) the 
osteopath was provided with a pro forma case history form to take notes throughout 
the consultation and a checklist of aspects of informed consent to be covered in each 
consultation; (4) the osteopath left the room to signal to the researcher the consultation 
had been completed; (5) the researcher entered the consultation room to stop 
recording the consultation and begin recording the semi-structured interview; (6) at 
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the interview’s conclusion the patients were offered a booking with a senior student 
osteopath in the tertiary clinic for ongoing care; (7) the osteopath was asked to write a 
brief guided reflection after each consultation. 
 
The consultations were completed at a tertiary teaching institute in New Zealand. Audio 
recordings of the consultation and patient interviews were completed using the Voice 
Memos application on an iPhone 6. All data were downloaded and stored on an 
encrypted flash-drive. All original files were immediately disposed of. Access to the 
information was given to the researcher and supervisors, upon request. All data will be 
retained for 10 years following the date of the consultation and securely stored in a 
locked filing cabinet at the researcher’s residence.  
 
After each consultation, the osteopath completed a 10 minute guided reflection to 
provide an insight into how they believed the informed consent process went. This 
aided the researcher in contextualising the phenomenon by understanding the 
osteopath’s intentions. However, this data was not included in analysis as it did not 
provide further insight in the patient experience. 
 
At the conclusion of the consultation, five of the six participating patients completed 
their interview. In one case, the interview was undertaken within 24 hours. 
 
Data Analysis 
All patient interviews were transcribed verbatim and anonymised prior to analysis. 
Each transcript was read through once initially while listening to the interview audio to 
ensure transcription reliability. An Interpretative Phenomenological Analysis 
framework was used to analyse this data (25). Each transcript was analysed 
individually with full immersion through reading and re-reading. Initial noting and 
developing of emergent themes were completed using a colour-coding system. 
Connections between these themes were sought before moving on to the next 
transcript. An electronic mind map was created using Debategraph to identify the type, 
and strength, of the relationship between the themes in each transcript. This rigorous 
analysis of the intricacies and connections between the themes were reviewed to 
ensure they reflected the true meaning of the collected data.  
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The last step was to categorise and name the final themes. Secondary thematic analysis 
was undertaken at a meeting of the researcher and one of the supervisory team. In this 
phase, the initial themes were defined, refined and renamed to determine the story of 
each theme and its link to data. An informative name for each theme that resonated 
with the researcher’s experiences interviewing the participant was added. This naming 
process also enlisted the help of a patient safety and quality specialist at a local hospital 
to bring an external and expert eye to the data and therefore enhance the face validity 
and credibility of the names assigned to themes (26, 27). 
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RESULTS 
The following comment by one respondent sums up the patient experiences of consent:  
 
“The word "consent" was not used at any stage.” (P1) 
 
Despite all participants describing their ongoing approval of treatment, none could 
recall any explicit use of the word consent. Their consent to osteopathic treatment 
appeared to take the form of ongoing permission throughout conversations in the 
consultation. The participants described multiple ways beyond the use of words, that 
they had provided consent. Five participants reported that their previous experiences 
as an osteopathic patient had already set their expectations about what would occur in 
the consultation. Four of these participants also suggested that volunteering to be 
physically present in an osteopathic consultation implied their consent. Two 
participants mentioned an ‘end justifies the means’ perspective which in their view, 
explained why giving consent was neither expected nor an explicit part of the 
consultation process. Feelings of comfort, being at ease, and having confidence in the 
osteopath’s clinical skills also emerged as key components of the patient experience of 
providing consent. Within this dynamic ongoing and interactive process, three 
significant themes emerged: the conversational nature of ongoing permission; 
Information processing and prioritisation; [and] Participatory nature of consent. 
 
Theme 1: Conversational nature of ongoing permission  
There were a variety of patient descriptions of how they delivered their permission for 
treatment. Firstly, a clear theme emerged from all six participants’ accounts that 
permission was giving in a relaxed and conversational manner throughout the entire 
consultation. This manner included both verbal and non-verbal elements.  
 
Secondly, all participants mentioned that the osteopath used descriptions and clinical 
justifications to gain consent for their approach to treatment. Five participants reported 
that the osteopath provided clinical justification for the diagnosis and use of treatment. 
Three participants felt the osteopath adjusted their explanations to suit their levels of 
understanding, These changes made information easier to understand because it was 
non-technical and concise. Most participants noted the close time proximity between 
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what the osteopath said they were about to do, and what was actually done. This 
increased patients’ levels of confidence as the relevance of the treatment became more 
immediately obvious.  
 
Table 1 Conversational nature of ongoing permission 
Example Interpretation 
“I'm focused on whether or not I can see the rationale for what 
they're going to do, and then I'm happy for them to proceed.” 
(P2) 
Clinical approach described and 
justified 
 
“Well, it was clear, he explained to me what he was gonna do 
and I understood what was gonna happen. It was very good… 
Oh, just enough to let me know what was gonna happen… 
Didn't go on for hours.” (P6) 
Expectations established 
Concise information 
“It (consent) was kind of like normal conversation, basically.” 
(P1) 
Consent through ongoing 
conversation 
 
“He got my hand and got my thumb and put it in the same place 
and found the same thing and said, "Now you press," so I could 
experience that.” (P2) 
Consent given after technique 
modeled 
 
“He asked me if I was feeling discomfort and I know that I was 
clenching my teeth at spots.” (P5) 
Non-verbal cues successfully 
communicating state of consent. 
“He guided me through the whole treatment with regard to how 
I would feel and kept saying, if anything was too much, I could 
stop it. He was kinda telling me I'm part of the deal here. Yeah, 
so I was quite happy with all of that.” (P5) 
Comfortable with withdrawing 
consent 
 
“As he was doing each part of the treatment, he was explaining 
it to me, all the way through.” (P1) 
Steady flow of information 
provided 
“It just kind of happens quick, you don't really realize that it's 
happening. It’s just basically explaining what's wrong and 
saying, "This is what I'm gonna and do," and then if you want 
that... If you feel comfortable with that, then that's what 
happens.” (P1) 
Consent within casual 
conversation. Comfort as 
component of consent. 
“As a patient, you're not focused on allowing this person to do... 
You don't have the concept of permission in your mind.” (P2) 
Patient focus 
 
Thirdly, participants identified a number of non-verbal cues such as nodding, grimacing, 
and following the osteopaths’ instructions as ways to successfully communicate their 
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permission. Five participants felt they were continuously reaffirming their consent for 
treatment by responding to the osteopath’s regular questions about levels of pain and 
being asked if everything was ‘OK’?. This continuous cycle of revisiting the patient’s 
verbal consent and communication assured two participants that they could withdraw 
permission at any time. Two participants reported that the osteopath used non-verbal 
communication such as modelling in less vulnerable areas of the body, such as the arm, 
to indicate what a technique will feel like, and help gain permission. 
 
Theme 2: Information processing and prioritisation  
The second significant theme that emerged encompassed how patients experienced 
information exchange and processing throughout the consultations. Two participants 
reported that processing the clinician’s information was in itself a positive form of 
treatment. Receiving and processing information about their presenting complaint, 
treatment, prognosis, and their suggested self-care strategies made five participants feel 
more empowered, reduced their stress, and challenged their own pre-set expectations 
around their behaviours, current self-care regime, and presenting complaint. This 
increased their confidence in themselves and the osteopath’s clinical skills , which in 
turn deprioritised the need, in their view, for an explicit consent procedure to be 
enacted. 
 
Table 2 Information processing and prioritisation 
Example Interpretation 
“Yeah, except for when he got some of the technical body 
parts, 'Cause, not having a medical background, I don't 
know any of them.” (P1) 
Terminology as barrier to understanding. 
“I'd rather they just focus on the job… I do have further 
questions, but I sort of just focus on the main points 'cause 
it really becomes information overload, actually.” (P2) 
Pain relief prioritised above clinical 
knowledge. Perceived relevance of 
information affects memory. Questions as 
a distraction from treatment. 
“There are some things I can recall quite easily, other 
things I can't. The fact that he made me feel better was 
okay.”  (P1) 
Memory and recall difficulty. 
Vulnerability. 
“Risks, risks? I didn't identify 'em or didn't lock into my 
head anyways.” (P5) 
Risk perception is patient specific. 
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“Well, for me, I'm an analytical type, so when he gives me 
the explanation I think of about 20 questions, but I don't 
wanna ask them... I'd rather they just focus on the job. I do 
have further questions, but I sort of just focus on the main 
points 'cause it really becomes information overload, 
actually.” (P2) 
Pain relief prioritised above clinical 
knowledge. Questions as a distraction 
from treatment. 
““I thought his explanations were probably the most 
clearest I've received… I think his articulate explanations 
engendered confidence… and makes you feel that this 
person knows what they're doing.”.” (P2) 
Patient empowerment through 
information.  
Clarity of information engendered 
confidence in practitioner. 
“He mostly gave me information, and I don't really need 
anymore at that point. “ (P3) 
Expansion of knowledge around condition  
“Everything that was happening was all being explained 
as we were going through the procedure.“ (P4) 
Ongoing information throughout 
consultation 
“When you get to my age and you get so many aches and 
pains, it's nice to have it in your mind that you understand 
it. Now, if you don't understand it, your brain drifts. It 
drifts with problems. So, you get up in the morning and 
you feel that thing and you say, "Oh, when is that gonna go 
away?" Now, if you can get a little bit more confidence 
boost, it takes a lot of the stress out.” (P6) 
Processing information as treatment.  
 
Five participants rated gaining pain relief from the consultation a higher priority than 
being made aware of, or informed about the clinical context. Three of these patients 
perceived themselves as damaged, vulnerable, or broken. This hindered their memory 
and recall of information as they did not feel adequately equipped to process 
information about their complaint. The speed of information delivery and use of 
technical terms were also mentioned as factors that reduced their processing and 
retention of information. This suggested that patients deprioritised clinical justification 
for the treatment they were about to receive, whether it was paced carefully or 
hurriedly completed, in favour immediate pain relief.   
 
Four participants mentioned they were given opportunities to ask questions. However, 
this was rarely used as it was perceived as a distraction from treatment or they felt that 
enough information had already been provided.  
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Despite the osteopath providing clear information about the potential risks and benefits 
of treatment, of interest is that one particular participant mentioned that they did not 
perceive these as risks, due to their previous positive experience receiving osteopathic 
treatment from other practitioners.  
 
Theme 3: Participatory nature of consent  
Engagement levels throughout the consultation was a common theme among 
participants. When asked about how they gave their consent, participants identified 
engagement and described it in a number of ways. Actively engaged participants 
acknowledged that they needed to involve themselves throughout the consultation 
through participation, shared decision-making, and a desire to understand what was 
happening to them. Four participants manifested this active engagement through the 
importance they ascribed to their self-care exercises, practitioner advice and knowing 
what their bodies needed. Many participants who were actively engaged felt their 
treatment was a collaborative experience with the osteopath. This experience of an 
interactive way of working acted as its own generator of consent.  
 
Table 3 Participatory nature of consent 
Example Interpretation 
“I like being participatory. I like hearing what 
things they're doing and how it's going to feel for 
me and that I can actually say, "Gee, that hurts," 
and he'll stop.” (P3) 
Acknowledged need to involve self throughout 
consultation. 
“With the flow of information... My feeling is that I 
was involved” (P3) 
Actively involved in decision making through 
conversation. Consultation is a collaborative 
partnership with osteopath. 
“He's given me some exercise to take away, which I 
like. Quite like to do that myself.” (P3) 
Actively engaged in self-care. 
“I could understand why some people would feel 
the desire to... To give in to do what they're told by 
a professional, I don't have that.” (P5) 
Appreciates importance of active participation 
throughout consultation 
“I figured that I'm sufficiently assertive that if 
something would bother me that I'd speak up, so I 
didn't really consciously pay a lot of attention. I 
know that he did say, "Hey, you're in charge."” 
Increased awareness of self improves patient 
autonomy. 
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On the other hand, passive engagement in the consultation was manifested in only one 
participant’s responses in which they revealed that they felt overwhelmed at times by 
the level of communication. This cognitive overload decreased their cognitive 
awareness of their physical self and their desire to take responsibility for their own 
personal healthcare. Informed consent, in this case, was centred on trust in the 
practitioner’s skills in the absence of any sound appreciation of chosen treatment 
strategies.  
  
(P5) 
“No, it just kind of happens quick, you don't really 
realize that it's happening kind of. So it's just 
basically explaining what's kind of wrong and 
saying, "This is what I'm gonna and do," and then 
you kind of... Obviously, you want that... If you feel 
comfortable with that, that's what you wanna do, 
then that's what happens.” (P4) 
Overwhelmed with speed of information delivery. 
Trust in practitioner decisions. 
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DISCUSSION 
The study has first and foremost affirmed that consent in osteopathy is an active and 
on-going process, one that is dynamically different to consent for other healthcare 
disciplines such as surgeries (8, 10, 28-30). In addition, the study has identified three 
themes related to patient consent and ongoing permission that expand our 
understanding of what constitutes “informed” consent from the perspective of the 
patient.  These are: ‘Conversational nature of ongoing permission’, ‘Information 
processing and prioritisation’, ‘Participatory nature of consent’. Each theme identifies a 
different aspect of patients’ experience of informed consent.  
 
The first identified theme ‘Conversational nature of ongoing permission’ describes the 
types of verbal and non-verbal communication that occurred throughout the 
consultation. Communication is defined as “the process of creating shared 
understanding” (31). Although gaining pre-treatment consent was deliberately 
attempted for each patient, the experience more commonly recalled was that of a 
conversation delivering ongoing agreement. The osteopath’s conversational approach 
used throughout the consultation created a shared understanding of permission being 
requested and granted by the patients. This corresponds with research suggesting that 
this is the preferred method of obtaining consent in osteopathy for patients (18). 
However, the participants did not consistently attribute to this conversation, as the 
granting of explicit verbal consent. This is possibly related to the absence of any 
standardised procedure to be followed that will comprehensively capture each patient’s 
informed consent (5).  
 
Gaining informed consent in osteopathy is an ethical and legal obligation as set out by 
the New Zealand Health and Disability Commissioner (HDC) and Osteopathic Council 
(OCNZ). According to the HDC, written consent for a healthcare procedure is only 
required if their risk for adverse effects is significant (32). When these significant risks 
are not present, consent can be obtained in any form, such as the conversational form 
experienced in this study, as long as the expected risks and benefits of treatment have 
been discussed (32, 33). However, if patients do not believe that explicit consent has 
been granted, this could cause potential ethico-legal issues to arise where the 
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practitioner has assumed consent because the patient was actively engaged in 
conversation. 
 
Despite the potential for misinterpretation, in this study, the continual provision of 
consent through the conversation did reassure patients that they could withdraw their 
consent at any time. Participants felt guided through the consultation and their 
responses to the osteopath’s communication constituted ongoing agreement for the 
treatment to continue. Specifically, these conversational interactions made participants 
feel they were consenting to the case history, examination, treatment, and post-
treatment care in real time, as required. This reiterates two important points: first that 
consent is not a one-time event, but a continual process of specific re-evaluation and re-
consenting (2, 4, 34). Second, that maintaining open communication about clinical 
reasoning is both desirable and important (5, 16, 35). Open communication impacts the 
comfort levels of patients, which in turn relates to them consenting to particular 
treatments or procedures (16, 36). The more relaxed a patient is about treatment 
processes, the more likely they will understand and consent to that procedure being 
done, even if, as some participants suggested, such reasoning was ostensibly of little 
relevance or value to them. 
 
The open continual communication participants experienced throughout the 
consultation consisted of both non-verbal and verbal cues. The non-verbal cues 
mentioned by participants included the osteopath’s open and confident posture, the 
patients’ own facial expressions, eye contact, and the environment of the clinical setting. 
These non-verbal cues worked to inform the osteopath what level of pain or discomfort 
the patient was experiencing with a movement or technique, or if they had 
misunderstood some information or instruction, and might withdraw consent to 
continue. Participants recalled that this was a successful form of communication 
because as the osteopath readily picked up on these cues, they responded appropriately 
by questioning if it was fine to continue, and if consent to treat was maintained. The 
dynamic interaction of non-verbal and verbal cues in a clinical setting have been found 
in previous research to help create patient-practitioner shared understanding (16, 37-
39) and shape and maintain informed consent (16, 34, 36, 40, 41). These findings also 
align with those in the research literature that shows that non-verbal communication 
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directly affects the quality of patient-centred communicative interaction and levels of 
patient satisfaction (37-39). In this study, the non-verbal cues worked dynamically with 
the verbal communication to ensure patients continued their active consenting through 
the entire consultation period. 
 
In terms of the content being verbally communicated, participants regarded having the 
clinical approach described and justified as the most important information upon which 
to base their consent. This suggests a robust link between the exchange of information 
about clinical reasoning and the provision of informed consent (16, 42, 43). The clinical 
information established their expectations for the imminent examination, treatment, 
and prognosis. Participants in this study who experienced and understood the clinical 
reasoning behind techniques felt more trust in the osteopath’s skills. This is a 
phenomenon that Fiscella et al. also identified (35). The importance of communicating 
clinical reasoning to patients also aligns with Carnes’ (12) findings that the absence of a 
communication around clinical justification was one of the main reasons for patient 
complaints. Therefore, communicating clear clinical justifications about prognosis and 
treatment is a vital constituent element of the ‘informed’ part of informed consent.  
 
The second theme identified in this research was ‘Information processing and 
prioritisation’. Participants were visiting the osteopath because they perceived 
themselves as broken or injured, and in a vulnerable state. Despite clinical reasoning 
being identified as an important aspect of gaining consent, they reported that knowing 
why a technique was being performed was less important than the potential it offered 
to relieve pain. A related factor was levels of trust participants felt based on their prior 
knowledge from previous experiences (34, 44). When participants were asked, many 
could not recall the risks explained by the osteopath, because they did not perceive the 
information provided as risks and trusted the practitioner’s clinical expertise. In turn, 
this meant that they retained less knowledge about the treatment process. This 
professional trust reduced the patients’ need for explicit consent.  
 
It is common for patients to remember approximately half of the information disclosed 
throughout the informed consent process (29, 30, 45-47). Prioritising pain relief and 
naïve trust attribution over information processing create medico-legal implications for 
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the informed consent process. If risks and benefits of possible treatment options fail to 
be explicit enough for patient comprehension, there is a risk that the informed consent 
hasn't been gained (2, 4, 32, 33, 43, 48-51). This emphasizes the point that although 
patients may believe that the information provided has been sufficient, it may not 
necessarily be understood (4, 43). As Leach et al (7) has noted in their study, 
participants mentioned that no one had discussed risks or if they did, they didn’t take 
any notice of them. Yet patients do feel it was necessary to be informed about likely 
risks and benefits of their possible treatment options (7, 15, 52, 53). Even where pain 
relief is a priority, or prior experience has created a high trust environment, it is 
incumbent upon the practitioner to ensure patient comfort and clear communication is 
maintained throughout the consultation. Thereby reducing the feeling of vulnerability 
and patient unease, from which possible complaints or concerns may result (12-14, 51). 
 
Participants’ consenting behaviours, and what information they retained, 
misunderstood, or assumed were also influenced by the terminology the osteopath used 
and the speed with which they presented the information. The anatomical terms used 
by the osteopath was regarded as unnecessary academic background and contributed 
to difficulties retaining information for consent purposes. The speed with which the 
osteopath explained the treatment processes was satisfactory for most participants. 
However, one comment highlighted the need for osteopaths to judge if their speed of 
information delivery and type of content prevents rather than facilitates clear 
understanding and informed consent. Further, the information exchange was almost 
entirely verbal. It has been recognised that for information to be learned effectively, 
information should be presented in three different ways (54). Research within 
osteopathy has shown that a combination of good verbal explanations, anatomical 
models, images and written information is preferred by patients (18, 50). Skillfully 
combining multiple verbal and visual modes to inform and educate patients can 
enhance memory recall of information provided for the consent process (2). In addition, 
to ensure that the effect extends well beyond a slight increase in information retention 
(55), the volume and relevance of information given must be considered, especially 
when that information is generically presented in writing (15, 56, 57). Personalised 
multimedia resources and structuring information into concise summaries of essential 
information could help minimise barriers to information retention and shift the focus 
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away from the dominant of oral delivery of the osteopath (15, 56, 57). Such steps will 
help practitioners and patients reach a robustly consented, understanding of treatment 
pathways through a more balanced use of verbal, visual and written communication 
strategies. 
 
The study identified a variety of effects participants experienced after receiving 
information in their consultations. The information the osteopath provided them with 
was a working diagnosis, clinical reasoning and rationale, risks and benefits of 
treatment, prognosis, and self-care advice. There was a significant affective 
consequence from patients receiving this information. Participants felt confident, 
empowered, and comfortable with their broadened knowledge of their condition. These 
findings identified that the comfort and confidence that participants experienced as a 
result of the quality of practitioner communication, play a significant role in the ongoing 
affirming of their consent. This reinforces that the ‘informed’ part is equally, if not more, 
important than the ‘consent’ itself. The research literature links this ‘informed’ point 
strongly with the ethos of patient-centred approaches to care, which benefits the 
therapeutic relationship, and makes patients’ participation in following treatment plans 
more likely (11, 43, 58, 59). Conversely, providing inadequate information risks 
negating the patients’ right to autonomy and consent, and could be viewed as failing to 
adhere to the ethico-legal duties of a healthcare practitioner (32, 33, 42). Consistently 
providing relevant information not only promotes patient-centred care but creates the 
conditions for patients to give consent which is informed by accurately explained and 
understood clinical reasoning (34). 
 
The third theme that emerged was the Participatory nature of consent. This means that 
patient perceptions of how informed consent was delivered and received depended 
upon how engaged they felt in the consultation process. Patient engagement and active 
participation in clinical discussions are linked to how open the communication is 
between the two parties (38). There were clear differences between participants who 
were actively engaged and those who were passively engaged in their consultation and 
care. The actively engaged participants often referred to having an increased awareness 
of self and a desire to participate in decision making throughout the consultation, which 
in turn made consent easier to give. This could indicate that these participants had 
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higher health literacy than others.  This varies from a phenomenon often found in the 
literature where patients wish to be informed but not involved (2, 60, 61). Conversely, a 
participant who was more inclined to be passive throughout the consultation 
mentioned that they felt no collaborative partnership with the osteopath. This 
manifested as a feeling of being overwhelmed, decreased awareness and interest of 
their physical body. This could have implications for providing consent for treatment as 
the patient does not feel informed and could feel pressured into consenting. Therefore, 
participation and engagement levels of patients can inform the degree to which consent 
was readily provided.  For participants who passively engaged throughout the 
consultation, patient-centred care was very low, the osteopath was put in charge of all 
decision-making and consent was given without a desire for information, a situation 
considered harmful to patient autonomy and shared-decision making (2, 3, 48, 49). It 
also carries a risk that these patients did not always recognise when they were 
providing permission for treatment, which could potentially lead to a complaint if any 
adverse event were to occur. On the other hand, engaged patients in the consultation 
expressed a sense of control around their condition and took personal responsibility for 
their own health and care. Informed consent was easier for these patients to give and 
recall.  
 
Participants felt that they engaged when the osteopath invited them to participate in 
demonstrating self-care exercises, such as stretches or encouraged responses within 
their conversation. For example, when the osteopath provided them with a decision to 
make, or information about alternative treatment options. One notable form of patient 
engagement was when the osteopath demonstrated a technique on a less vulnerable 
area of their body to set expectations and gain consent to apply the technique to the 
affected area. This allowed patients to experience and feel what a technique would be 
like to determine whether they would consent to the same technique being applied to 
the sensitive area, such as the front of the neck. Modeling techniques in a less 
vulnerable area beforehand set patient expectations about what they will experience 
with the technique. Although the study did not directly address cultural issues of 
treatment it is worth noting that within a multicultural population, or with patients who 
have experienced domestic violence in New Zealand (62), certain body areas could have 
increased emotional and physical sensitivity or cultural significance. This respects their 
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personal and cultural background and allows them to consent safely or withdraw 
consent should they feel uncomfortable or culturally unsafe.  
 
For participants in this research, previous positive experiences of osteopathic care were 
identified as an important variable leading to implicit consent as these patients entered 
the consultation with pre-established expectations. This meant that a number of 
patients already felt an automatic level of comfort and safety throughout the 
consultation, and implied their consent by allowing the consultation to proceed without 
dissent or complaint. Although forms of implied consent was a common feature for 
these participants, it should not be the only form of consent obtained. However, this 
accounts for explicit consent, particularly verbal consent, being largely absent from 
participants’ focus or responses. Other expressions of implied consent manifested as 
patients’ expression of confidence in the osteopath, active participation, and being 
physically present in an osteopathic consultation.  
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CONCLUSION 
This study provides an insight into the patient experience of informed consent in 
osteopathy. This study suggests that the patient experience of consent is more than an 
explicit verbal confirmation of comfort and safety or a prescriptive protocol applied 
uniformly across all consultations. The significant variables that influence the consent 
process are the quality of verbal and non-verbal, communication between the osteopath 
and their patient. The study reaffirms that gaining consent throughout each subsequent 
treatment is not just a medico-ethical imperative, but builds a sense of treatment 
partnership; even if it at times it may feel arduous, repetitive or considered unnecessary 
for both the osteopath and patient. In essence, omitting some form of on-going strategic 
consent process could constitute a risk to the therapeutic relationship.  
 
The study has indicated that when patients feel involved, informed, and invested in 
their personal healthcare, they are likely to give truly informed consent, be it explicit or 
implied for the treatment process. Greater understanding of the patient’s perspective of 
the consent experience can lead to improved professional development in the way 
osteopaths communicate with their patients to gain their consent for treatment. The 
findings from this study are clinically relevant for all manual therapists and could be 
implemented immediately to encourage mutually safe patient-centred care and have 
implications for the number and frequency of concerns voiced, or complaints laid 
against osteopaths.   
 
Limitations of this study include patient variability of informed consent experiences, 
small sample size, and that the osteopath works in a New Zealand osteopathic teaching 
clinic which could provide a consent process that is not necessarily generalisable to the 
osteopathic population in New Zealand or internationally. Another limitation that has 
been identified is that the patients had different responses to the treatment, which 
could be a result of the osteopath’s behaviour changing towards each patient. However, 
these limitations do not affect the findings significantly as the patient experience of 
informed consent has been rigorously analysed and is valid for the context within which 
it was researched.  
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Previous research around informed consent has primarily focused on hospitals, doctors, 
and surgeries (8, 10, 28, 48).  This study has highlighted a potential difference in the 
very nature of informed consent as it relates to ongoing treatment especially in manual 
therapies, rehabilitation and complementary medicine contexts.   
 
This study opens a new area of potential future research within a complementary 
medicine context.  Potential research questions relate to what may prove to be an 
evolving and dynamic process of consent: one that changes and develops as treatment 
progresses. For example, does pain override considerations of risk on early visits and 
once pain is reduced or better managed does the consideration of risk or new pain 
effect the consent process.  Do evolving goal setting and assessment processes in 
collaboration with the patient become an integral part of informed consent as the 
treatment timeline advances and does a meaningful consent process change and evolve  
 
The limitation of transferability is noted. Similar studies could be replicated to include 
more osteopaths from different areas, to gain an understanding of the patient 
experience that could be more transferability to a population. The osteopath’s 
experience of informed consent could be researched to see if it aligns with that of their 
patients. The impact and importance of ongoing consent and communication research 
for both osteopaths and patients could generate useful findings and conclusions that 
give more informed guidance to practising osteopaths, their regulatory environment, 
and national governance bodies. Research into strategies that minimize the effects of 
age, education, cognitive function, and anxiety (10, 45, 47, 63) on information retention 
could be of use.  
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Supplementary Material:  
Consolidated criteria for reporting qualitative studies (COREQ): 32-item checklist  
 
Tong, A., Sainsbury, P., & Craig, J. (2007). Consolidated criteria for reporting qualitative 
research (COREQ): A 32-item checklist for interviews and focus groups. International 
Journal for Quality in Health Care, 19(6), 349–357. doi: 10.1093/intqhc/mzm042  
 
The criteria has been formatted as: Item number – Guide questions/description  
 
DOMAIN 1: RESEARCH TEAM AND REFLEXIVITY  
Personal Characteristics  
1. Interviewer/facilitator – Which author/s conducted the interview or focus group? 
Principal researcher (Caitlin Kilpin)  
 
2. Credentials – What were the researcher’s credentials? E.g. PhD, MD  
BAppSc (Human Biology), Master of Osteopathy student.  
 
3. Occupation – What was their occupation at the time of the study?  
Student  
 
4. Gender – Was the researcher male or female?  
Female  
 
5. Experience and training – What experience or training did the researcher have?  
Two years of clinical experience in an osteopathic tertiary teaching clinic; no previous 
research training  
 
Relationship with participants  
6. Relationship established – Was a relationship established prior to study 
commencement?  
The researcher had spent time with the participating osteopath during time in the 
tertiary teaching clinic. There was no relationship with the patient participants of this 
study prior to its commencement. 
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7. Participant knowledge of the interviewer – What did the participants know about the 
researcher? e.g. personal goals, reasons for doing the research.  
All participants recruited understood that the researcher was completing this study to 
partially fulfill the requirements for the Master of Osteopathy degree.  
 
8. Interviewer characteristics – What characteristics were reported about the 
interviewer/facilitator? e.g. Bias, assumptions, reasons and interests in the research topic  
The researcher developed an interest in the topic of informed consent during the 
practical component of her undergraduate and masters degree.  
 
DOMAIN 2: STUDY DESIGN  
Theoretical framework  
9. Methodological orientation and Theory – What methodological orientation was stated 
to underpin the study? e.g. grounded theory, discourse analysis, ethnography, 
phenomenology, content analysis  
Interpretative phenomenology analysis 
 
Participant selection  
10. Sampling – How were participants selected? e.g. purposive, convenience, consecutive, 
snowball  
Purposive sampling for osteopath and convenience sampling for patients.  
 
11. Method of approach – How were participants approached? e.g. face-to-face, telephone, 
mail, email  
Osteopath: Email invitation 
Patients: Formal telephone conversation.  
 
12. Sample size – How many participants were in the study?  
Osteopath: n=1  
Patients: n=6  
Total: n=7 participants  
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13. Non-participation – How many people refused to participate or dropped out? Reasons? 
No participants refused to participate or dropped out throughout the study. 
 
Setting  
14. Setting of data collection – Where was the data collected? e.g. home, clinic, workplace 
A single tertiary osteopathic teaching clinic  
 
15. Presence of non-participants – Was anyone else present besides the participants and 
researchers?  
No 
 
16. Description of sample – What are the important characteristics of the sample? e.g. 
demographic data, date  
No demographic or age data was collected. All participants were above the age of 16 
years old as a requirement to participant. 
 
Data collection  
17. Interview guide – Were questions, prompts, guides provided by the authors? Was it 
pilot tested?  
The interview questions were piloted prior to data collection using two people not 
related to osteopathy or the study.  
  
18. Repeat interviews – Were repeat interviews carried out? If yes, how many?  
No repeat interviews were carried out.  
 
19. Audio/visual recording – Did the research use audio or visual recording to collect the 
data?  
Audio recording was used to collect the data.  
 
20. Field notes – Were field notes made during and/or after the interview or focus group? 
Brief field notes were made with timestamps throughout the interview. Further field 
notes were made after the interview. 
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21. Duration – What was the duration of the interviews or focus group?  
Audio recorded interviews lasted between 15 and 25 minutes.  
 
22. Data saturation – Was data saturation discussed?  
Following the conclusion of the patient interviews, the researcher and primary 
supervisor discussed data saturation. It was decided that the richness of the data 
obtained from 6 patient interviews was sufficient to achieve the research aim.  
 
23. Transcripts returned – Were transcripts returned to participants for comment and/or 
correction? Yes – Transcripts were returned to the participants. No comments or 
corrections were made.  
 
DOMAIN 3: ANALYSIS AND FINDINGS  
Data analysis  
24. Number of data coders – How many data coders coded the data?  
One data coder- the principal researcher (Caitlin Kilpin)  
 
25. Description of the coding tree – Did authors provide a description of the coding tree? 
A description of the coding tree is not present in the manuscript.  
 
26. Derivation of themes – Were themes identified in advance or derived from the data?  
All themes were derived from the data.  
 
27. Software – What software, if applicable, was used to manage the data?  
DebateGraph 
 
28. Participant checking – Did participants provide feedback on the findings?  
No participants provided feedback on the findings. 
 
Reporting  
29. Quotations presented – Were participant quotations presented to illustrate the themes 
/ findings? Was each quotation identified? e.g. participant number  
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Yes- Quotations were extracted from the data and referenced to each participant e.g. P1, 
P2 
 
30. Data and findings consistent – Was there consistency between the data presented and 
the findings?  
Yes.  
 
31. Clarity of major themes – Were major themes clearly presented in the findings?  
Yes.  
 
32. Clarity of minor themes – Is there a description of diverse cases or discussion of minor 
themes?  
Yes, three major themes were discussed and no minor themes were identified.  
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Information sheet for osteopaths 
An explorative phenomenological study of six patients’ lived experiences of informed 
consent in an osteopathic clinical consultation. 
Start date: 24/08/2016 
Finish date: 24/08/2017 
 
About this research  
You are invited to participate in a research project investigating the informed consent process 
used in an osteopathic consultation. Consent is a key constituent of any consultation with a 
health professional. You have been invited to participate because it is believed that you value 
informed consent as a tool to improve collaboration between practitioner and patient. It is 
important to understand the lived experiences in this context to ensure the processes used are 
adequate to fit yours and the patient’s needs. 
 
What will happen in this research?  
You are invited to take part in a research study involving six patients. The events will be as 
follows:  
• The researcher will explain the purpose of the research and discuss any questions or 
concerns you may have. You will then be asked to read and sign a written consent 
form.  
• You will work with the researcher to create an informed consent checklist and guided 
written reflection template. 
• You will approach six patients who are new to your practice and inform them about 
the study prior to their appointment time. Information sheets will be given to you for 
this reason. You will ask the patient if there are interested in participating. If yes, you 
will let them know that you will pass their contact details onto the researcher. The 
researcher will then determine the patient’s eligibility and explain the research 
process. Written consent will be gained at this point.  
• At the scheduled appointment time, you will be asked to use a voice recorder to 
record the entirety of the consultation with the patient. The checklist that was created 
at the beginning will be used throughout these consultations. 
• At the conclusion of the consultation, you will be asked to complete the written 
reflection. The opportunity to edit these reflections will remain until 48 hours after the 
consultation. 
• This process will be repeated six times. 
 
What do I need to do? 
You will be asked to: 
• Invite six new patients participants to participate. 
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• Collaborate with the researcher to create a checklist of items that need to be addressed 
in an informed consent process. This checklist must be used with each patient 
participant. 
• Collaborate with the researcher to create a guided written reflection that will be used 
at the conclusion of each studied consultation.  
• Agree to audio record the entirety of your initial consultation with the six pateints. 
 
You will have the opportunity to review and edit any of the six written reflections up to 48 
hours after the consultation.  
 
How will the data be stored? 
All research data will be saved to the researcher’s personal computer hard-drive in a 
password-protected file. A copy of the password-protected file will be made to a flash-drive 
to be used as a back-up. You will have the opportunity to keep a copy of the written 
reflections and audio from the consultations. This may be used within a professional 
development reflective framework. All research data will be retained for 10 years following 
the date of the consultation and securely stored in a locked filing cabinet at the lead 
researcher’s residence. After which, it will be disposed of. 
 
Information about withdrawing from the study   
You may withdraw your data and subsequent participation from the study up to five working 
days after your final reflection. 
 
Personal information confidentially and security 
Your confidentiality in this research cannot be guaranteed. The research party and patient 
participants will know that you are participating. If a patient participant mentions your name 
or clinic throughout data collection, a pseudonym will be assigned throughout transcription. 
There will be no identifiable features of your identity or clinic in the final script. At the 
conclusion of the study, you will have the opportunity to utilise the guided reflections, 
recorded consultations, and published interview data for their individual professional 
development. However, this would limit your confidentiality and anonymity. 
 
You will have the opportunity to receive an electronic copy of the research findings at the 
conclusion of the study. The results from this study may be published in a journal. 
 
If you have any further questions about this research please don’t hesitate to contact the 
following:  
Researcher: 
Caitlin Kilpin 
Tel: 027 847 4223 
Email: caitlinkilpin@gmail.com 
 
Research Supervisor: 
Principal Supervisor: 
Dale Sheehan 
dsheehan@unitec.ac.nz  
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An explorative phenomenological study of six patients’ lived experiences of informed 
consent in an osteopathic clinical consultation. 
Start date: 24/08/2016  
Finish date: 24/08/2017 
 
 
Participant name: ___________________________________________________________  
 
I have reviewed the information sheet about this research project. I have read and 
understood the information sheet presented to me. I have had the opportunity to 
discuss any queries or concerns regarding this research with the researcher, Caitlin 
Kilpin, and am satisfied with the explanations given.  
 
I understand that participating in this project is my own choice. I consent to 
collaborating with the researcher to design an ideal informed consent checklist and 
guided written reflection template. I consent to approaching six new patients in my 
private practice to participate, audio recording their initial consultations, and 
completing six written reflections afterward. I recognise that I may withdraw my own 
data (audio from six consultations and six written reflections) from the study up to five 
working days after the final reflection. I understand that pseudonyms will be used to 
disguise my identity and any information reported will not identify me, or my clinic, in 
any way. I acknowledge that I will have the opportunity to review and edit my six 
written reflections, and the researcher will be in contact within 48 hours of the 
accompanying consultation to make this opportunity available. I have been provided 
with the researcher's contact details as well.   
 
I understand that anything I say in six written reflections will remain confidential and 
that only the researcher (Caitlin Kilpin) and her supervisors will have access to these. I 
acknowledge that I may keep a copy of the guided written reflections and audio from 
the consultations to use within a reflective professional development framework.  
 
I understand the six written reflections will be securely stored on the researcher’s hard-
drive and an encrypted back-up will be stored in safe and separate locations. I 
acknowledge that all data will be retained for a period of 10 years, and kept at the 
researcher's secure residence. At the conclusion of this time, all data will be destroyed. I 
give permission for the analysed findings published from this research project to be 
drawn upon and utilised to inform future research projects. I also give permission for 
anonymised data to be utilised in future publications of this research project.  
 
I acknowledge that I can see the finished research document and that the results from 
this study may be published in a journal. 
 
I have had adequate time to consider everything and I give my informed consent to be a 
part of this research project.  
 
I know whom to contact to discuss any questions or concerns about this project.  
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The researcher is: Caitlin Kilpin  
Caitlinkilpin@gmail.com  
Tel: 027 847 4223  
 
Participant Signature: ................................ Date: .................................  
 
 
Project explained by: ................................  Signature: ................................ Date: .................... 
 
 
Thank you for participating in this research.  
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Information sheet for patients 
An explorative phenomenological study of six patients’ lived experiences of informed 
consent in an osteopathic clinical consultation. 
Start date: 24/08/2016 
Finish date: 24/08/2017 
 
About this research  
You are invited to participate in a research project exploring the informed consent processes 
that your osteopath uses. Consent is giving your permission to the osteopath to examine and 
treat you. Consent and the patient experience in an osteopathic setting has not been well 
researched. This research will guide further research which hopes to provide an insight in 
how consent can be improved to fit your needs as a patient. Please note that participation in 
this research will not impact on your osteopathic treatment or management.  
 
What do I need to do? 
If you are expressing interest in the research project, your osteopath will provide the 
researcher with your contact details. The researcher will contact you to discuss whether you 
are eligible to participate. You will have the opportunity to discuss any questions or concerns 
with the researcher. You will then be asked to read and sign a written consent form to 
demonstrate your understanding and willingness to participate. This study involves recording 
the audio from your initial appointment and participating in an interview (approximately 30 
minutes) afterward. You will be asked to a series of questions about the appointment and the 
audio from this interview will be recorded. The interview may be conducted by phone or 
face-to-face up to 48 hours after your appointment. 
 
Data Transcription 
An external party with no association to the research project will be asked to transcribe the 
interview audio. This external party has signed a written confidentiality agreement. You will 
have the opportunity to review your interview transcript and you may use this opportunity to 
add or remove any information and check for accuracy. The researcher will contact you for 
this reason. The only people who will have access to your individual interview data after 
transcription will be the researcher and research supervisors. The researcher will transcribe 
the data specifically related to informed consent that was recorded throughout the 
appointment. The osteopath and research team will have access to this data. 
 
Information about withdrawing from the study  
You may withdraw your own data (interview and appointment audio recordings) from the 
study up to five working days after your interview.  
 
Personal information confidentially and security 
Your real name and information will be kept strictly confidential. All information will be 
stored in an encrypted file on the researcher's personal computer and flash drive. All original 
files will be deleted. The only people who will have access to your interview data and 
personal information will be Caitlin Kilpin and her research supervisors. All data will be 
retained for 10 years following the date of the consultation and securely stored in a locked 
filing cabinet at the researcher’s residence. All efforts will be made to anonymise your 
identity. Throughout the transcription process pseudonyms will be used and any identifying 
features such as description of clothing, treatment, and area of pain will be removed before 
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publication. Due to the small sample size, there is a possibility that your data may be 
identifiable to the osteopath. This will not effect the treatment or management that you 
receive from the osteopath. However, the opportunity to review your interview transcripts 
will be given to highlight parts of the interview you believe could be used to identify you. As 
the results from this study may be published in a journal, the option will be given to remove 
these parts from the transcript completely or make them unpublishable.  
 
You will have the opportunity to receive an electronic copy of the research findings at the 
conclusion of the study. The researcher will contact you to make these opportunities 
available.  
 
If you have any further questions about this research please don’t hesitate to contact the 
following: 
 
Researcher: 
Caitlin Kilpin 
Tel: 027 847 4223 
Email: caitlinkilpin@gmail.com 
 
Research Supervisor: 
Principal Supervisor: 
Dale Sheehan 
dsheehan@unitec.ac.nz 
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An explorative phenomenological study of six patients’ lived experiences of informed 
consent in an osteopathic clinical consultation. 
Start date: 24/08/2016 
Finish date: 24/08/2017 
 
 
Participant name: ___________________________________________________________  
 
I have reviewed the information sheet about this study. I have read and understand the 
information sheet presented to me. I have had the opportunity to discuss any queries or 
concerns regarding this research with the researcher, Caitlin Kilpin, and am satisfied 
with the explanations given. 
 
I understand that participating in this project is my own choice. I consent to one audio 
throughout an initial osteopathic appointment and one audio recording during an 
interview. I recognise that I may withdraw my own data (audio recordings from 
appointment and interview) from the study up to five working days after the interview. 
I understand that pseudonyms will be used to disguise my identity and any information 
reported will not identify me in any way to people outside of the research project.  
 
I understand that anything I say or do during the interview recordings will remain 
confidential and that only the researcher (Caitlin Kilpin), her supervisors, and a 
transcriber will have access to these transcripts. I understand that due to the small 
sample size, the osteopath may be able to identify what I said in the interview, however, 
this will not disadvantage or affect my ongoing treatment with the osteopath. I 
acknowledge that I will have the opportunity to review and edit a copy of the interview 
transcript to ensure that I am comfortable with what may be published, and the 
researcher will be in contact to make this opportunity available. I have been provided 
with the researcher's contact details as well.   
 
I understand the audio recordings will be securely stored on the researcher’s hard-drive 
and an encrypted back-up will be stored in safe and separate locations. I acknowledge 
that all data will be retained for a period of 10 years, and kept at the researcher's secure 
residence. At the conclusion of this time, all data will be destroyed. I give permission for 
the analysed findings published from this research project to be drawn upon and 
utilised to inform future research projects. I also give permission for anonymised data 
to be utilised in future publications of this research project.  
 
I acknowledge that I can see the finished research document and that the results from 
this study may be published in a journal. 
 
I have had adequate time to consider everything and I give my informed consent to be a 
part of this research project. 
  
I know whom to contact to discuss any questions or concerns about this project.  
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The researcher is: Caitlin Kilpin  
caitlinkilpin@gmail.com  
Tel: 027 847 4223 
 
Participant Signature: .................................... Date: .................................  
 
 
Project explained by: ................................ Signature: ................................ Date: ...................... 
 
 
Thank you for participating in this research. 
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Appendix F: Transcribers Agreement 
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Research Title: An explorative phenomenological study of six patients’ lived experiences of 
informed consent in an osteopathic clinical consultation. 
 
Researcher Name: Caitlin Kilpin 
  
Address: Unitec Osteopathy Clinic 41, 139 Carrington Road, Mount Albert, Auckland, 1025 
 
Phone number: 027 847 4223 
 
Email: caitlinkilpin@gmail.com 
 
I ___________________________________________________ (full name - please print) 
agree to treat in absolute confidence all information that I become aware of in the course of 
transcribing the interviews or other material connected with the above research topic. I 
agree to respect the privacy of the individuals mentioned in the interviews that I am 
transcribing. I will not pass on in any form information regarding those interviews to any 
person or institution. On completion of transcription I will not retain or copy any 
information involving the above project.   
 
I am aware that I can be held legally liable for any breach of this confidentiality agreement, 
and for any harm incurred by individuals if we disclose identifiable information contained in 
the audiotapes and/or files to which we will have access. 
 
 
Signature: ………………………………………………………. Date: ………………………………………… 
 
UREC REGISTRATION NUMBER: 2016:1048 
This study has been approved by the UNITEC Research Ethics Committee from  24/08/2016 to   
24/08/2017. If you have any complaints or reservations about the ethical conduct of this research, you 
may contact the Committee through the UREC Secretary (ph: 09 815-4321 ext 8551). Any issues you 
raise will be treated in confidence and investigated fully, and you will be informed of the outcome. 
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Informed Consent Checklist 
 
Attribute Completed 
Consent gained for observation and examination  
Working diagnosis explained  
Treatment option one explained: 
• Risks 
• Benefits 
• Expected outcome 
 
Treatment option two explained: 
• Risks 
• Benefits 
• Expected outcome 
 
Patient involvement in decision-making  
Opportunity for patient questions  
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Guided Written Reflection  
 
Please answer the following questions while reflecting on your recent consultation. 
 
Questions: 
1. Describe how you gained informed consent from the patient for examination and 
treatment.  
 
2. Describe any positive or negative aspects during the process of informed consent. 
 
3. Tell me about the information you provided about their examination and treatment.  
a. How much information did you provide about treatment risks and benefits? 
b. Tell me how this information was presented. 
c. Did the patient understand the information? If yes, how did you know? 
 
4. Tell me how much information you provided about subsequent or alternative 
treatment options. 
 
5. Describe how you involved the patient in decision-making throughout the 
consultation?  
 
6. Was the patient given the opportunity to ask questions throughout the entire process? 
 
7. Is there anything else you would like to add or reflect on? 
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Interview Guide for Semi-structured Interviews 
 
Prior to osteopathic appointment:  
• Thank the participant for their involvement in this research.  
• Introduction – Begin with introducing myself and ask the participant to do the same. 
• Read through and explain information sheet and consent form. Ensure the patient 
understands their role in the research.  
• Ensure the participant understands the audio from the appointments and interviews 
will be recorded. 
• Ask the participant if they have any queries or concerns. 
• Confirm/sign the consent form. 
• Schedule a time to complete the interview within 48 hours of the consultation.  
 
At the time of the interview, ask the participant if they would like to begin the interview in a 
particular way (i.e. Karakia, prayer). 
 
Throughout the interview, participants will be asked to reflect on their recent experience as a 
patient in an osteopathic clinic. 
Questions: 
1. Describe how you gave the osteopath permission to examine and treat you.  
2. Describe any positive or negative aspects during the process of giving permission. 
3. Tell me about the information you received about your examination and treatments.  
a. How much information were you given about your treatment? 
b. Tell me how this information was presented. 
c. Was the information easily understood? How was this understanding 
expressed to the osteopath? 
d. Did anything happen throughout the appointment that you weren’t expecting? 
4. Tell me how much information you were given about subsequent or alternative 
treatment options. 
5. Describe how the osteopath involved you in decision-making throughout the 
consultation?  
6. Were you given the opportunity to ask questions throughout the entire process? 
7. Is there anything else you would like to add or reflect on? 
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• Thank the participant for their involvement in the study 
• Ask if there are any concerns and reaffirm the confidentiality of data. 
• Remind the participant of subsequent processes and the ability to withdraw within 
five working days. 
• Ensure contact information of researcher, and supervisor is given. 
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Appendix J: DebateGraph Maps 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: These maps are optimally viewed on a computer screen and are available for 
public viewing. Each node provides an interactive opportunity to see how it is related to 
other nodes. The lines connected to the central node are colour co-ordinated depending 
on the type of the relationship they represent. The thickness of these relationships 
relates to the rating of the relationship strength on a scale of 1-9. 
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Map 1 – Full Map 
Available to view at: https://debategraph.org/informedconsent 
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Map 2 – Conversational Nature of Informed Consent 
Available to view at: https://debategraph.org/conversational 
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Map 3 – Information Processing and Prioritisation 
Available to view at: https://debategraph.org/informationprocessing 
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Map 4 – Participatory Nature of Consent  
Available to view at: https://debategraph.org/patientcentred 
  
  
 
 
 
Appendix K: International Journal of Osteopathic 
Medicine: Guidelines for Authors  
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INTRODUCTION  
The Editors of the Journal welcome contributions for publication from the following 
categories: Letters to the Editor and Editorials, Reviews and Original Research articles, 
Protocols, Commentaries, Education, Clinical and Practice articles (Case Studies). 
  
The Guidelines are separated into the following sections:  
A Online Submission 
B Types of Contributions 
C General Guidance 
D Preparation of the Manuscript 
E Specific Guidance for Original Research Articles F Specific Guidance for Protocols 
G Post Acceptance  
 
Types of contributions  
For all the following types of contributions authors are requested to consider the 
international readership of the journal and to be aware of the need to explain local 
contexts or define terminology where these are likely not to be commonly understood 
internationally. Word limits exclude tables, figures and reference list.  
 
Letters to the Editor (up to 1,000 words)  
As is common in biomedical journals the Editorial Board welcomes critical responses to 
any aspect of the journal. In particular, letters that point out deficiencies and that add 
to, or further clarify points made in a recently published work, are welcomed. The 
Editorial Board reserves the right to offer authors of papers the right of rebuttal, which 
may be published alongside the letter.  
 
Reviews and Original Articles (2,000 - 5,000 words)  
Authors should select "Review Article" or "Full Length Article" at the submission stage 
when submitting either a Review or an Original Research article. 
These should be either (i) reports of new findings related to osteopathic medicine that 
are supported by research evidence. These should be original, previously unpublished 
works; or (ii) a critical or systematic review that seeks to summarise or draw 
conclusions from the established literature on a topic relevant to osteopathic medicine.  
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Please see specific guidance below for original research articles and the requirement to 
submit a checklist from the appropriate reporting guideline together with your paper as 
a guide to the editors and reviewers of your paper. The checklists for each reporting 
guideline can be found on the EQUATOR website. Checklists should be uploaded at 
submission as "Checklist" file types.  
 
Short review (1,500-3,000 words)  
The drawing together of present knowledge in a subject area, in order to provide a 
background for the reader not currently versed in the literature of a particular topic. 
Shorter in length than and not intended to be as comprehensive as that of the critical or 
systematic review paper. These papers typically place more emphasis on outlining 
areas of deficit in the current literature that warrant further investigation.  
 
Research Note (up to 1,500 words)  
Authors should select "Research Paper" at submission stage when submitting a 
Research Note. Findings of interest arising from a larger study but not the primary aim 
of the research endeavour, for example short experiments aimed at establishing the 
reliability of new equipment used in the primary experiment or other incidental 
findings of interest, arising from, but not the topic of the primary research. Includes 
further clarification of an experimental protocol after addition of further controls, or 
statistical reassessment of raw data.  
 
Preliminary Findings (1,500-2,500 words)  
Authors should select "Preliminary Report" at submission stage when submitting a 
Preliminary Findings paper. 
Presentation of results from pilot studies which may establish a solid basis for further 
investigations. Format similar to original research report but with more emphasis in 
discussion of future studies and hypotheses arising from pilot study.  
 
Professional Commentaries (up to 2,000 words)  
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Includes articles that do not fit into the above criteria as original research. Includes 
commentaries and essays especially in regards to history, professional identity, clinical 
scope and development, and political and legal aspects of osteopathic medicine.  
 
Clinical Practice  
Authors should select the article type "Clinical Commentary" when submitting a Clinical 
Practice paper - there will be an option within the submission process to further select 
the type of format as below. Authors are encouraged to submit papers in one of the 
following formats: Case Report, Case Problem, and Evidence in Practice.  
 
i. Case Reports - usually document the management of one patient, with an emphasis on 
presentations that are unusual, rare or where there was an unexpected response to 
treatment (e.g. an unexpected side effect or adverse reaction). Authors may also wish to 
present a case series where multiple occurrences of a similar phenomenon are 
documented. Preference will be given to reports that are prospective in their planning 
and utilise Single System Designs, including objective measures.  
 
ii. The aim of the Case Problem is to provide a more thorough discussion of the 
differential diagnosis of a clinical problem. The emphasis is on the clinical reasoning 
and logic employed in the diagnostic process.  
 
iii. The purpose of the Evidence in Practice report is to provide an account of the 
application of the recognised Evidence Based Medicine process to a real clinical 
problem. The paper should be written with reference to each of the following five steps: 
1. Developing an answerable clinical question. 2. The processes employed in searching 
the literature for evidence. 3. The appraisal of evidence for usefulness and applicability. 
4. Integrating the critical appraisal with existing clinical expertise and with the patient's 
unique biology, values, and circumstances. 5. Reflect on the process (steps 1-4), 
evaluating effectiveness, and identifying deficiencies.  
 
Please note for Case Reports there is a requirement to submit a checklist from the CARE 
reporting guideline together with your paper as a guide to the editors and reviewers of 
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your paper. The checklists for each reporting guideline can be found on the EQUATOR 
website  
 
Protocols (1,500 - 2,000 words)  
Authors should select "Method Article" at submission stage when submitting a Protocol.  
The IJOM accepts the submission of protocols of randomised interventions, systematic 
reviews and meta-analyses, observational studies, and selected phase I and II studies 
(novel intervention for a novel indication; a strong or unexpected beneficial or adverse 
response; or a novel mechanism of action), with the overall aim to encourage good 
principles in clinical research design.  
 
The editors are looking for studies that will appeal to a wide general readership. The 
question being addressed and the planned design and analysis will need to be as 
original as possible, topical, and valid. All protocols will be subject to the journal's usual 
peer review process.  
 
Masterclasses  
Authors should select "Feature Article" at submission stage when submitting a 
Masterclass. The purpose of the Masterclass section is to describe in detail clinical 
aspects of osteopathic medicine or topics relevant to osteopathic clinicians. This may 
focus on specific treatment techniques, a particular management approach, 
management of a specific clinical entity, or topics such as understanding research 
design, use of measurement in practice, and professional issues such as clinical 
governance and audit. The majority of Masterclasses are commissioned by the Editors, 
but if you wish submit an idea for a Masterclass for consideration of publication please 
contact Oliver Thomson (O.Thomson@bso.ac.uk) or David Evans 
(dwe@backpainclinic.co.uk).  
• The article should be between 3500-4000 words in length excluding references. 
• A short summary should precede the main body of the article overviewing the 
contents.  
• The introduction should review the relevant literature and put the subject matter into 
context. 
• The main body of the text will describe the technique or approach in detail.  
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Illustrations are considered an essential part of the Masterclass in order to fully inform 
the reader and a minimum of six photographs or line drawings are required.  
In addition, authors may wish to include supplementary material which would be 
available online only. This may include, for example, podcasts, videoclips, animation 
sequences, high-resolution colour images, author reflections on the Masterclass, and 
background datasets. Authors are invited to refer to previously published Masterclasses 
as examples.  
 
New section - Osteopathic Education:  
This new section of the International Journal of Osteopathic Medicine provides accounts 
of new teaching and learning methods, curriculum development and implementation, 
and assessment strategies in undergraduate and post-qualifying osteopathic education, 
and continuous professional development initiatives. It also serves as a forum for 
communication between osteopathic educators, policy developers and those involved in 
clinical practice. Papers which focus on osteopathic education in both classroom and 
clinical/practice environments are welcomed for this new section of the journal. It is 
essential that the evidence-base to osteopathic education is developed and this is 
reflected in papers submitted for publication. In alignment with the journal's overall 
Aims and Scope, papers submitted for consideration of publication should be relevant to 
an international audience, even if they are national in scale of study. The editorial team 
wish to encourage submission of papers that demonstrate:  
• Innovation and development of education 
• Creativity in teaching and learning and assessment strategies  
• Evaluation and quality assurance of academic standards 
• Advancement of practice-based education 
• Collaborative interdisciplinary education initiatives 
• Delivery and evaluation of education within osteopathic and related services.  
 
If your submission constitutes original research or is in the form of a review, please see 
Specific guidance below for original research articles and the requirement to submit a 
checklist from the appropriate reporting guideline together with your paper as a guide 
to the editors and reviewers of your paper. The checklists for each reporting guideline 
can be found on the EQUATOR website.  
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When submitting a paper for the Education Section authors will be asked to select the 
option "Education" during the submission process. Authors are first asked to identify 
the type of paper they are submitting (ie. Review Article, Full Length Article) before 
being asked to confirm whether it is to be considered for the Education Section.  
 
Author Enquiries  
For enquiries relating to the submission of articles (including electronic submission 
where available) please visit this journal's homepage at 
http://www.elsevier.com/ijosm. You can track accepted articles at 
http://www.elsevier.com/trackarticle and set up e-mail alerts to inform you of when an 
articles status has changed. Also accessible from here is information on copyright, 
frequently asked questions and more.  
 
Contact details for questions arising after acceptance of an article, especially those 
relating to proofs, will be provided by the publisher.  
 
Submission checklist  
You can use this list to carry out a final check of your submission before you send it to 
the journal for review. Please check the relevant section in this Guide for Authors for 
more details.  
 
Ensure that the following items are present:  
 
One author has been designated as the corresponding author with contact details: • E-
mail address 
• Full postal address  
 
All necessary files have been uploaded: 
Manuscript: 
• Include keywords 
• All figures (include relevant captions) 
• All tables (including titles, description, footnotes) 
• Ensure all figure and table citations in the text match the files provided • Indicate 
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clearly if color should be used for any figures in print Graphical Abstracts / Highlights 
files (where applicable)  
Supplemental files (where applicable) Cover Letter 
Conflict of Interest Statement 
Author agreement  
 
Further considerations 
• Manuscript has been 'spell checked' and 'grammar checked' 
• All references mentioned in the Reference List are cited in the text, and vice versa  
• Permission has been obtained for use of copyrighted material from other sources 
(including the Internet) 
• Relevant declarations of interest have been made 
• Journal policies detailed in this guide have been reviewed 
• Referee suggestions and contact details provided, based on journal requirements  
 
For further information, visit our Support Center.  
 
BEFORE YOU BEGIN  
Ethics in publishing  
Please see our information pages on Ethics in publishing and Ethical guidelines for 
journal publication.  
 
A statement of Ethical Approval is required to be completed during online submission 
and included in the Conflict of Interest file and uploaded as a separate file in the final 
stage of the online submission system. Examples of such statements are given below: 
"The study design and procedures were approved by XXXX (Approval number: XXXX)". 
"The study was granted an exemption by the institutional review board".  
 
Human and animal rights  
If the work involves the use of human subjects, the author should ensure that the work 
described has been carried out in accordance with The Code of Ethics of the World 
Medical Association (Declaration of Helsinki) for experiments involving humans; 
Uniform Requirements for manuscripts submitted to Biomedical journals. Authors 
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should include a statement in the manuscript that informed consent was obtained for 
experimentation with human subjects. The privacy rights of human subjects must 
always be observed.  
 
All animal experiments should comply with the ARRIVE guidelines and should be 
carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and 
associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National 
Institutes of Health guide for the care and use of Laboratory animals (NIH Publications 
No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that 
such guidelines have been followed.  
 
Patient anonymity  
Studies on patients or volunteers require ethics committee approval and informed 
consent which should be documented in the manuscript.  
 
Patients have a right to privacy. Therefore identifying information, including patients' 
images, names, initials, or hospital numbers, should not be included in videos, 
recordings, written descriptions, photographs, and pedigrees unless the information is 
essential for scientific purposes and you have obtained written informed consent for 
publication in print and electronic form from the patient (or parent, guardian or next of 
kin where applicable). If such consent is made subject to any conditions, Elsevier must 
be made aware of all such conditions. Evidence of written consent must be provided to 
Elsevier on request.  
 
Even where consent has been given, identifying details should be omitted if they are not 
essential. If identifying characteristics are altered to protect anonymity, such as in 
genetic pedigrees, authors should provide assurance that alterations do not distort 
scientific meaning and editors should so note.  
 
Authors submitting manuscripts as Case Reports, Case Problems, and Evidence in 
Practice should ensure that they have received consent from patients who are the 
subject of such reports. A statement to this effect should be included in the manuscript.  
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If such consent has not been obtained, personal details of patients included in any part 
of the paper and in any supplementary materials (including all illustrations and videos) 
must be removed before submission.  
 
Declaration of interest  
All authors must disclose any financial and personal relationships with other people or 
organizations that could inappropriately influence (bias) their work. Examples of 
potential conflicts of interest include employment, consultancies, stock ownership, 
honoraria, paid expert testimony, patent applications/ registrations, and grants or other 
funding. Authors must disclose any interests in two places: 1. A summary declaration of 
interest statement in the title page file (if double-blind) or the manuscript file (if single-
blind). If there are no interests to declare then please state this: 'Declarations of 
interest: none'. This summary statement will be ultimately published if the article is 
accepted. 2. Detailed disclosures as part of a separate Declaration of Interest form, 
which forms part of the journal's official records. It is important for potential interests 
to be declared in both places and that the information matches. More information.  
A Conflict of Interest statement should be uploaded as a separate file in the final stages 
of the online submission system.  
 
Conflict of Interest file: A Conflict of Interest file is required and should include 
statements of 1) Conflict of Interest, (2) Funding Sources, and (3) ethical approval 
details (if applicable) under these headings. If some, or all three, do not apply, please 
still include the headings stating "None" / "Not applicable". Clinical Trial Registry name 
and registration number and Acknowledgments may be added if applicable as 4th and 
5th headings. For revised manuscripts this information must be transferred to the 
manuscript file.  
 
Submission declaration and verification  
Submission of an article implies that the work described has not been published 
previously (except in the form of an abstract or as part of a published lecture or 
academic thesis or as an electronic preprint, see 'Multiple, redundant or concurrent 
publication' section of our ethics policy for more information), that it is not under 
consideration for publication elsewhere, that its publication is approved by all authors 
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and tacitly or explicitly by the responsible authorities where the work was carried out, 
and that, if accepted, it will not be published elsewhere in the same form, in English or 
in any other language, including electronically without the written consent of the 
copyright-holder. To verify originality, your article may be checked by the originality 
detection service Crossref Similarity Check.  
 
IJOM Author Contribution Statement  
All manuscripts submitted to the journal should be accompanied by an Author 
Agreement file - this is a statement of author contribution. The purpose of the Statement 
is to give appropriate credit to each author for their role in the study. All persons listed 
as authors should have made substantive intellectual contributions to the research. To 
qualify for authorship each person listed should have made contributions in each of the 
following;  
1) Contributions to conception and design; data acquisition; data analysis and 
interpretation; 
2) Drafting of manuscript, or critical revision for important intellectual content; 
3) All authors must have given approval to the final version of the manuscript 
submitted for consideration to publish.  
Acquisition of funding; provision of resources; data collection; or general supervision, 
alone, is not sufficient justification for authorship. Contributors who do not meet the 
criteria for authorship as outlined above should be listed in the Acknowledgements 
section. Acknowledgements may include contributions of technical assistance, proof 
reading and editing, or assistance with resources and funding. The statement may be 
published in the paper as appropriate.  
Example of suggested format (note the use of author initials). 
AB conceived the idea for the study. AB and CD contributed to the design and planning 
of the research. All authors were involved in data collection. AB and EF analysed the 
data. AB and CD wrote the first draft of the manuscript. EF coordinated funding for the 
project. All authors edited and approved the final version of the manuscript.  
 
Changes to authorship  
Authors are expected to consider carefully the list and order of authors before 
submitting their manuscript and provide the definitive list of authors at the time of the 
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original submission. Any addition, deletion or rearrangement of author names in the 
authorship list should be made only before the manuscript has been accepted and only 
if approved by the journal Editor. To request such a change, the Editor must receive the 
following from the corresponding author: (a) the reason for the change in author list 
and (b) written confirmation (e-mail, letter) from all authors that they agree with the 
addition, removal or rearrangement. In the case of addition or removal of authors, this 
includes confirmation from the author being added or removed.  
Only in exceptional circumstances will the Editor consider the addition, deletion or 
rearrangement of authors after the manuscript has been accepted. While the Editor 
considers the request, publication of the manuscript will be suspended. If the 
manuscript has already been published in an online issue, any requests approved by the 
Editor will result in a corrigendum.  
 
Clinical trial results  
In line with the position of the International Committee of Medical Journal Editors, the 
journal will not consider results posted in the same clinical trials registry in which 
primary registration resides to be prior publication if the results posted are presented 
in the form of a brief structured (less than 500 words) abstract or table. However, 
divulging results in other circumstances (e.g., investors' meetings) is discouraged and 
may jeopardise consideration of the manuscript. Authors should fully disclose all 
posting in registries of results of the same or closely related work.  
Authors should include the Clinical Trial Registration number in the Conflict of Interest 
statement (see above) at original submission stage, and will be required to transfer the 
number into the manuscript file for revised articles.  
 
Original research articles  
The text of original research for a quantitative or qualitative study is typically 
subdivided into the following sections:  
 
Introduction  
Describe the wider context of the topic and its relevance providing selected citations 
that evidence and underpin the context. Identify key relevant research and briefly 
describe the strengths and weaknesses of past work and identify the gaps in the 
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literature and key questions that are pertinent to the topic and practice. Build on this 
descriptive account to establish an argument for the manuscript’s focus and end the 
introductory section with the aims of the research that is being reported and or the 
research questions.  
 
Materials and Methods  
Describe your selection of observational or experimental participants (including 
controls). Identify the methods, apparatus (manufacturer's name and address in 
parenthesis) and procedures in sufficient detail to allow workers to reproduce the 
results. Give references and brief descriptions for methods that have been published but 
are not well known; describe new methods and evaluate limitations.  
Indicate whether procedures followed were in accordance with the ethical standards of 
the institution or regional committee responsible for ethical standards. Do not use 
patient names or initials. Take care to mask the identity of any participants in 
illustrative material.  
 
Results  
Present results in a logical sequence in the text, tables and illustrations. Do not repeat in 
the text all the data in the tables or illustrations. Emphasise or summarise only 
important observations.  
 
Discussion  
Emphasise the new and important aspects of the study and the conclusions that follow 
from them. Do not repeat in detail data or other material given in the introduction or 
the results section. Include implications of the findings and their limitations, and 
include implications for future research. Relate the observations to other relevant 
studies. Link the conclusion with the goals of the study, but avoid unqualified 
statements and conclusions not completely supported by your data. State new 
hypothesis when warranted, but clearly label them as such. Recommendations, when 
appropriate, may be included.  
 
Conclusion  
 108 
A summary of the pertinent findings and, relevance of the study and implications of the 
study for future research.  
 
Appendices  
Appendices may also be used to publish supplementary files online, to which a 
reference should be made in the printed article. Material that is to be included in 
appendices should be submitted in separate "e-component" files.  
 
Types of research designs  
Manuscripts are required to adhere to recognized reporting guidelines relevant to the 
research design used. These identify matters that should be addressed in your paper. 
These are not quality assessment frameworks and your study need not meet all the 
criteria implied in the reporting guideline to be worthy of publication in the journal.  
 
To improve the quality of reporting of other categories of research, the IJOM supports 
the initiatives available through the EQUATOR Network (Enhancing the Quality and 
Transparency Of health Research) which houses a database of all reporting guidelines 
for health research (http://www.equator-network.org). All authors of research articles 
and reviews are required to complete and submit a checklist from the appropriate 
reporting guideline together with your paper as a guide to the editors and reviewers of 
your paper. The checklists for each reporting guideline can be found on the EQUATOR 
website. A copy of the complete checklist should accompany your submission. The 
checklist should be uploaded at submission as a "Checklist" file type.  
 
Reporting guidelines endorsed by the journal are listed below:  
 
Observational cohort, case control and cross sectional studies - STROBE - Strengthening 
the Reporting of Observational Studies in Epidemiology  
Quasi-experimental/non-randomised evaluations - TREND - Transparent Reporting of 
Evaluations with Non-randomized Designs  
Randomised (and quasi-randomised) controlled trial - CONSORT - Consolidated 
Standards of Reporting Trials  
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Study of Diagnostic accuracy/assessment scale - STARD - Standards for the Reporting of 
Diagnostic Accuracy Studies  
Quality Appraisal of Reliability Studies - QAREL 
Consensus-based Clinical Case Reporting Guideline Development - CARE  
Systematic Review of Controlled Trials - PRISMA - Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses  
Systematic Review of Observational Studies - MOOSE - Meta-analysis of Observational 
Studies in Epidemiology  
Qualitative researchers might wish to consult the guideline listed below:  
Qualitative studies - COREQ - Consolidated criteria for reporting qualitative research. 
Tong, A., Sainsbury, P., Craig, J., 2007. Consolidated criteria for reporting qualitative 
research (COREQ): a 32- item checklist for interviews and focus groups. International 
Journal for Quality in Health Care 19 (6), 349-357.  
 
Protocols  
Organisation of a Protocol - the following need to be adequately addressed. 
• Title 
• Abstract/Summary - this should provide a concise description of the purpose of the 
Protocol and should not exceed 200 words. 
• Background, including rationale and any previous systematic review(s).  
• Keywords - provide 4-10 keywords. 
• Principal investigator(s); contact details. 
• Aim(s). 
• Design (randomised, double-blind) - including inclusion and exclusion criteria; 
intervention(s)/ method; primary and secondary endpoint(s); side-effects reporting 
and quantification 
• Statistical analysis - including sample size and power calculations; type of analysis; 
statistical testing. 
• Ethical issues - including ethics committee approval; informed consent form and 
information sheet.  
• Publication plan. 
• Time required - an estimation of the time required to run the protocol should be given 
per separate step and for the whole protocol, including reporting. 
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• Funding source(s). 
• References.  
 
Randomised controlled trials  
The International Journal of Osteopathic Medicine has adopted the proposal from the 
International Committee of Medical Journal Editors(ICMJE) (see a recent Editorial in 
Manual Therapy 
http://www.sciencedirect.com/science/article/pii/S1356689X1200238X, Editorial: 
"Clinical trial registration inphysiotherapy journals: Recommendations from the 
International Society of Physiotherapy Journal Editors"), which requires, as a condition 
of consideration for publication of clinical trials, registration in a public trials registry. 
Trials must register at or before the onset of patient enrolment. The clinical trial 
registration number should be included at the end of the abstract of the article in the 
final published version. For the peer review process however the clinical trial 
registration number should be included in the Conflict of Interest Statement (see 
below). For this purpose, a clinical trial is defined as any research project that 
prospectively assigns human subjects to intervention or comparison groups to study 
the cause and effect relationship between a medical intervention and a health outcome. 
Studies designed for other purposes, such as to study pharmacokinetics or major 
toxicity (e.g. phase I trials) would be exempt. Further information can be found at 
http://www.icmje.org. Clinical Trials that commence after 1st June 2013 must be 
registered to be considered for publication in the International Journal of Osteopathic 
Medicine. From January 2014 the International Journal of Osteopathic Medicine will not 
be able to accept any unregistered Clinical Trial papers. By 2015 the journal will not be 
able to publish any Clinical Trials that are unregistered prior to recruitment of the first 
participant.  
 
Copyright  
This journal offers authors a choice in publishing their research: Open Access and 
Subscription.  
 
For Subscription articles  
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Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing 
Agreement' (for more information on this and copyright, see 
http://www.elsevier.com/copyright). An e-mail will be sent to the corresponding 
author confirming receipt of the manuscript together with a 'Journal Publishing 
Agreement' form or a link to the online version of this agreement. Subscribers may 
reproduce tables of contents or prepare lists of articles including abstracts for internal 
circulation within their institutions. Permission of the Publisher is required for resale or 
distribution outside the institution and for all other derivative works, including 
compilations and translations (please consult http://www.elsevier.com/permissions). 
If excerpts from other copyrighted works are included, the author(s) must obtain 
written permission from the copyright owners and credit the source(s) in the article. 
Elsevier has preprinted forms for use by authors in these cases: please consult 
http://www.elsevier.com/permissions.  
 
For Open Access articles  
Upon acceptance of an article, authors will be asked to complete an 'Exclusive License 
Agreement' (for more information see http://www.elsevier.com/OAauthoragreement). 
Permitted reuse of open access articles is determined by the author's choice of user 
license (see http://www.elsevier.com/openaccesslicenses.  
 
Retained author rights  
As an author you (or your employer or institution) retain certain rights. For more 
information on author rights for:  
 
Subscription articles please see http://www.elsevier.com/journal-authors/author-
rights-and-responsibilities.  
 
Open access articles please see http://www.elsevier.com/OAauthoragreement. Elsevier 
supports responsible sharing  
Find out how you can share your research published in Elsevier journals.  
 
Role of the funding source  
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You are requested to identify who provided financial support for the conduct of the 
research and/or preparation of the article and to briefly describe the role of the 
sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; 
in the writing of the report; and in the decision to submit the article for publication. If 
the funding source(s) had no such involvement then this should be stated.  
 
This disclosure should be uploaded in the Conflict of Interest statement file in the final 
stages of manuscript submission (see above).  
 
Funding body agreements and policies  
Elsevier has established a number of agreements with funding bodies which allow 
authors to comply with their funder's open access policies. Some funding bodies will 
reimburse the author for the Open Access Publication Fee. Details of existing 
agreements are available online. 
After acceptance, open access papers will be published under a noncommercial license. 
For authors requiring a commercial CC BY license, you can apply after your manuscript 
is accepted for publication.  
 
Open access  
This journal offers authors a choice in publishing their research:  
 
Subscription  
• Articles are made available to subscribers as well as developing countries and patient 
groups through our universal access programs. 
• No open access publication fee payable by authors. 
Open access  
• Articles are freely available to both subscribers and the wider public with permitted 
reuse. 
• An open access publication fee is payable by authors or on their behalf, e.g. by their 
research funder or institution.  
 
Regardless of how you choose to publish your article, the journal will apply the same 
peer review criteria and acceptance standards.  
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For open access articles, permitted third party (re)use is defined by the following 
Creative Commons user licenses:  
 
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)  
For non-commercial purposes, lets others distribute and copy the article, and to include 
in a collective work (such as an anthology), as long as they credit the author(s) and 
provided they do not alter or modify the article.  
 
The open access publication fee for this journal is USD 1700, excluding taxes. Learn 
more about Elsevier's pricing policy: http://www.elsevier.com/openaccesspricing.  
 
Green open access  
Authors can share their research in a variety of different ways and Elsevier has a 
number of green open access options available. We recommend authors see our green 
open access page for further information. Authors can also self-archive their 
manuscripts immediately and enable public access from their institution's repository 
after an embargo period. This is the version that has been accepted for publication and 
which typically includes author-incorporated changes suggested during submission, 
peer review and in editor-author communications. Embargo period: For subscription 
articles, an appropriate amount of time is needed for journals to deliver value to 
subscribing customers before an article becomes freely available to the public. This is 
the embargo period and it begins from the date the article is formally published online 
in its final and fully citable form. Find out more.  
 
This journal has an embargo period of 12 months.  
 
Elsevier Publishing Campus  
The Elsevier Publishing Campus (www.publishingcampus.com) is an online platform 
offering free lectures, interactive training and professional advice to support you in 
publishing your research. The College of Skills training offers modules on how to 
prepare, write and structure your article and explains how editors will look at your 
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paper when it is submitted for publication. Use these resources, and more, to ensure 
that your submission will be the best that you can make it.  
 
Language (usage and editing services)  
Please write your text in good English (American or British usage is accepted, but not a 
mixture of these). Authors who feel their English language manuscript may require 
editing to eliminate possible grammatical or spelling errors and to conform to correct 
scientific English may wish to use the English Language Editing service available from 
Elsevier's WebShop.  
 
Submission  
Our online submission system guides you stepwise through the process of entering your 
article details and uploading your files. The system converts your article files to a single 
PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required 
to typeset your article for final publication. All correspondence, including notification of 
the Editor's decision and requests for revision, is sent by e-mail.  
 
Submit your article  
Please submit your article via https://www.evise.com/profile/api/navigate/IJOSM.  
 
Referees  
Please submit the names and institutional e-mail addresses of several potential 
referees. For more details, visit our Support site. Note that the editor retains the sole 
right to decide whether or not the suggested reviewers are used.  
 
(D) PREPARATION  
Submitted papers should be relevant to an international audience and authors should 
not assume knowledge of national practices, policies, law, etc. Authors should consult a 
recent issue of the journal for style if possible. Since the journal is distributed all over 
the world, and as English is a second language for many readers, authors are requested 
to write in plain English and use terminology which is internationally acceptable.  
 
Abbreviations  
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Avoid the use of abbreviations unless they are likely to be widely recognised. In 
particular you should avoid abbreviating key concepts in your paper where readers 
might not already be familiar with the abbreviation. Any abbreviations which the 
authors intend to use should be written out in full and followed by the letters in 
brackets the first time they appear, thereafter only the letters without brackets should 
be used. Statistics - Standard methods of presenting statistical material should be used. 
Where methods used are not widely recognised explanation and full reference to widely 
accessible sources must be given.  
 
References  
There are no strict requirements on reference formatting at submission. References can 
be in any style or format as long as the style is consistent. Where applicable, author(s) 
name(s), journal title/book title, chapter title/article title, year of publication, volume 
number/book chapter and the pagination must be present. Use of DOI is highly 
encouraged. The reference style used by the journal will be applied to the accepted 
article by Elsevier at the proof stage. Note that missing data will be highlighted at proof 
stage for the author to correct. However, should you wish to use the Vancouver 
numbered style adopted by the journal, full guidance is given below.  
 
Review process  
The decision to publish a paper is based on an editorial assessment and peer review. 
Initially all papers are assessed by an editor of the journal. The prime purpose is to 
decide whether to send a paper for peer review and to give a rapid decision on those 
that are not.  
 
Manuscripts going forward to the review process are reviewed by members of an 
international expert panel. All such papers will undergo a double blind peer review by 
two or more reviewers. All papers are subject to peer review and the Journal takes 
every reasonable step to ensure author identity is concealed during the review process. 
The Editors reserve the right to the final decision regarding acceptance.  
 
Double-blind peer review - This journal uses double-blind review, which means that 
both the reviewer and author name(s) are not allowed to be revealed to one another for 
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a manuscript under review. The identities of the authors are concealed from the 
reviewers, and vice versa. To facilitate anonymity, the author's names and any reference 
to their addresses should only appear on the title page.  
 
Blinded manuscript (no author details): The main body of the paper (including the 
references, figures, tables) should not include any identifying information, such as the 
authors' names or affiliations. Authors should also ensure that the place of origin of the 
work or study, and/or the organization(s) that have been involved in the 
study/development are not revealed in the manuscript – “X” can be used in the 
manuscript and details can be completed if the manuscript is processed further through 
the publication process.  
 
Manuscript Layout  
The manuscript with a font size of 12 or 10 pt double-spaced with wide margins (2.5 cm 
at least) and number pages consecutively beginning with the Title Page. Depending on 
the paper type (see above) this should include the title, abstract, key words, text, 
references, tables, figure legends, figures, appendix. Microsoft Word or similar 
programme should be used. Please check your typescript carefully before you send it 
off, both for correct content and typographic errors. It is not possible to change the 
content of accepted typescripts during production. 
To facilitate anonymity, the author's names and any reference to their addresses should 
only appear on the title page. Please check your typescript carefully before you send it 
off, both for correct content and typographic errors. It is not possible to change the 
content of accepted typescripts during production.  
 
Text  
The text of observational and experimental articles is usually, but not necessarily, 
divided into sections with the headings; introduction, methods, results, results and 
discussion. In longer articles, headings should be used only to enhance the readability. 
Three categories of headings should be used:  
• major headings should be typed in capital letter in the centre of the page and 
underlined (i.e. INTRODUCTION)  
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• secondary ones should be typed in lower case (with an initial capital letter) in the left 
hand margin and underlined (i.e. Participants).  
• minor ones typed in lower case and italicised (i.e. questionnaire).  
Do not use 'he', 'his' etc. where the sex of the person is unknown; say 'the patient' etc. 
Avoid inelegant alternatives such as 'he/she'.  
 
NEW SUBMISSIONS  
Submission to this journal proceeds totally online and you will be guided stepwise 
through the creation and uploading of your files. The system automatically converts 
your files to a single PDF file, which is used in the peer-review process.  
 
As part of the Your Paper Your Way service, you may choose to submit your manuscript 
as a single file to be used in the refereeing process. This can be a PDF file or a Word 
document, in any format or lay- out that can be used by referees to evaluate your 
manuscript. It should contain high enough quality figures for refereeing. If you prefer to 
do so, you may still provide all or some of the source files at the initial submission. 
Please note that individual figure files larger than 10 MB must be uploaded separately  
 
Formatting requirements  
There are no strict formatting requirements but all manuscripts must contain the 
essential elements needed to convey your manuscript, for example Abstract, Keywords, 
Introduction, Materials and Methods, Results, Conclusions, Artwork and Tables with 
Captions and "Contribution of Paper" (where applicable).  
 
If your article includes any Videos and/or other Supplementary material, this should be 
included in your initial submission for peer review purposes.  
 
Divide the article into clearly defined sections.  
 
Figures and tables embedded in text  
Please ensure the figures and the tables included in the single file are placed next to the 
relevant text in the manuscript, rather than at the bottom or the top of the file. Ensure 
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that figures and tables are referred to in the body of the text and that they are clearly 
labelled.  
 
ALL SUBMISSIONS  
The following documents are needed for all submissions.  
 
Title page (with author details) - This should include the title, authors' names and 
affiliations, and a complete address for the corresponding author including telephone 
and e-mail address.  
 
Blinded manuscript (no author details) - The main body of the paper (including the 
references, figures, tables) should not include any identifying information, such as the 
authors' names or affiliations.  
 
Covering letter - to the editor in which you detail authorship contributions and other 
matters you wish the editors to consider.  
 
Implications for Practice  
At submission stage, authors of reviews and original research articles are required to 
provide three to four bullet points outlining what the manuscript adds to the literature. 
This should succinctly and accurately summarise the key new knowledge resulting from 
the study along with the implications for clinical, educational or research practice as 
appropriate for the focus of the manuscript. These should be placed after the Abstract 
and before the main body of the text.  
 
Essential title page information  
• Title. Concise and informative. Titles are often used in information-retrieval systems. 
Avoid abbreviations and formulae where possible. 
• Author names and affiliations. Please clearly indicate the given name(s) and family 
name(s) of each author and check that all names are accurately spelled. You can add 
your name between parentheses in your own script behind the English transliteration. 
Present the authors' affiliation addresses (where the actual work was done) below the 
names. Indicate all affiliations with a lower- case superscript letter immediately after 
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the author's name and in front of the appropriate address. Provide the full postal 
address of each affiliation, including the country name and, if available, the e-mail 
address of each author.  
• Corresponding author. Clearly indicate who will handle correspondence at all stages of 
refereeing and publication, also post-publication. This responsibility includes answering 
any future queries about Methodology and Materials. Ensure that the e-mail address is 
given and that contact details are kept up to date by the corresponding author.  
• Present/permanent address. If an author has moved since the work described in the 
article was done, or was visiting at the time, a 'Present address' (or 'Permanent 
address') may be indicated as a footnote to that author's name. The address at which 
the author actually did the work must be retained as the main, affiliation address. 
Superscript Arabic numerals are used for such footnotes.  
 
GENERAL GUIDANCE  
Abstract  
Both qualitative and quantitative research approaches should be accompanied by a 
structured abstract of no more than 250 words. Commentaries and Essays may 
continue to use text based abstracts of no more than 150 words. All original articles 
should include the following headings in the abstract as appropriate: Background, 
Objective, Design, Setting, Methods, Participants, Results, and Conclusions. As an 
absolute minimum: Objectives, Methods, Results, and Conclusions must be provided for 
all original articles. Abstracts for reviews of the literature (in particular systematic 
reviews and meta- analysis) should include the following headings as appropriate: 
Objectives, Data Sources, Study Selection, Data Extraction, Data Synthesis, Conclusions. 
Abstracts for Case Studies should include the following headings as appropriate: 
Background, Objectives, Clinical Features, Intervention and Outcomes, Conclusions.  
 
Keywords  
Include four to ten keywords in alphabetical order, which accurately identify the 
paper's subject, purpose, method and focus. These should be indexing terms that may 
be published with the abstract with the aim of increasing the likely accessibility of your 
paper to potential readers searching the literature. Therefore, ensure keywords are 
descriptive of the study. Use the Medical Subject Headings (MeSH®) thesaurus or 
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Cumulative Index to Nursing and Allied Health (CINAHL) headings where possible (see 
http://www.nlm.nih.gov/mesh/meshhome.html).  
 
Abbreviations- Avoid the use of abbreviations unless they are likely to be widely 
recognised. In particular you should avoid abbreviating key concepts in your paper 
where readers might not already be familiar with the abbreviation. Any abbreviations 
which the authors intend to use should be written out in full and followed by the letters 
in brackets the first time they appear, thereafter only the letters without brackets 
should be used.  
 
Acknowledgments  
One or more statements should specify (a) contributions that need acknowledging, but 
do not justify authorship (b) acknowledgments of technical support (c) 
acknowledgments of financial and material support, specifying the nature of the 
support. Persons named in this section must have given their permission to be named. 
Authors are responsible for obtaining written permission from those acknowledged by 
name since readers may infer their endorsement of the data and conclusions. Authors 
should include Acknowledgments in the Conflict of Interest statement at original 
submission stage, and will be required to transfer the Acknowledgments into the 
manuscript file for revised articles.  
 
Statement of Competing Interests  
When submitting a manuscript you will need to consider if you, or any of your co-
authors, are an Editor or Editorial Board member of the International Journal of 
Osteopathic Medicine. If this is the case you will need to upload a Conflict of Interest 
statement at submission. Example statement, which may require editing, is as follows: { 
Name of author } is an Editor of the Int J Osteopath Med; { Name of author } is a member 
of the Editorial Board of the Int J Osteopath Med but was not involved in review or 
editorial decisions regarding this manuscript.  
Formatting of funding sources  
List funding sources in this standard way to facilitate compliance to funder's 
requirements:  
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Funding: This work was supported by the National Institutes of Health [grant numbers 
xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and 
the United States Institutes of Peace [grant number aaaa].  
 
It is not necessary to include detailed descriptions on the program or type of grants and 
awards. When funding is from a block grant or other resources available to a university, 
college, or other research institution, submit the name of the institute or organization 
that provided the funding.  
 
If no funding has been provided for the research, please include the following sentence:  
This research did not receive any specific grant from funding agencies in the public, 
commercial, or not-for-profit sectors.  
 
Artwork  
File Formatting for Artwork &Illustrations - General points 
• Make sure you use uniform lettering and sizing of your original artwork.  
• Save text in illustrations as "graphics" or enclose the font. 
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol. • 
Number the illustrations according to their sequence in the text. 
• Use a logical naming convention for your artwork files. 
• Provide captions to illustrations separately. 
• Produce images near to the desired size of the printed version. 
• Submit each figure as a separate file.  
 
A detailed guide on electronic artwork is available on our website: 
http://www.elsevier.com/ artworkinstructions  
 
Please do not: 
• Supply embedded graphics in your word processor (spreadsheet, presentation) 
document. 
• Supply files that are optimised for screen use (like GIF, BMP, PICT, WPG); the 
resolution is too low. • Supply files that are too low in resolution. 
• Submit graphics that are disproportionately large for the content.  
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Electronic artwork 
General points 
• Make sure you use uniform lettering and sizing of your original artwork.  
• Embed the used fonts if the application provides that option. 
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, 
Symbol, or use fonts that look similar. 
• Number the illustrations according to their sequence in the text.  
• Use a logical naming convention for your artwork files. 
• Provide captions to illustrations separately. 
• Size the illustrations close to the desired dimensions of the published version. 
• Submit each illustration as a separate file. 
A detailed guide on electronic artwork is available. 
You are urged to visit this site; some excerpts from the detailed information are given 
here. 
Formats 
If your electronic artwork is created in a Microsoft Office application (Word, 
PowerPoint, Excel) then please supply 'as is' in the native document format. 
Regardless of the application used other than Microsoft Office, when your electronic 
artwork is finalized, please 'Save as' or convert the images to one of the following 
formats (note the resolution requirements for line drawings, halftones, and 
line/halftone combinations given below): 
EPS (or PDF): Vector drawings, embed all used fonts. 
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 
dpi. 
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a 
minimum of 1000 dpi. TIFF (or JPEG): Combinations bitmapped line/half-tone (color or 
grayscale), keep to a minimum of 500 dpi. 
Please do not: 
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these 
typically have a low number of pixels and limited set of colors; 
• Supply files that are too low in resolution; 
• Submit graphics that are disproportionately large for the content.  
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Tables, Illustrations and Figures  
Tables, illustrations and figures should be placed on separate pages as separate 
electronic files and not placed within the manuscript. Each table, illustration or figure 
should be accompanied by a number (e.g. Table 1) and a brief description of the content 
of the table, figure or illustration, below the table, illustration or figure. All tables, 
illustrations or figures should be referred to in the manuscript.  
 
Illustrations and tables that have appeared elsewhere must be accompanied by written 
permission to reproduce them from the original publishers. This is necessary even if 
you are an author of the borrowed material. Borrowed material should be 
acknowledged in the captions in the exact wording required by the copyright holder. If 
not specified, use this style: `Reproduced by kind permission of . . . (publishers) from . . . 
(reference).' Identifiable clinical photographs must be accompanied by written 
permission from the patient.  
 
References   
Please ensure that every reference cited in the text is also present in the reference list 
(and vice versa). Any references cited in the abstract must be given in full. . Citation of a 
reference as 'in press' implies that the item has been accepted for publication.  
 
Reference links  
Increased discoverability of research and high quality peer review are ensured by 
online links to the sources cited. In order to allow us to create links to abstracting and 
indexing services, such as Scopus, CrossRef and PubMed, please ensure that data 
provided in the references are correct. Please note that incorrect surnames, 
journal/book titles, publication year and pagination may prevent link creation. When 
copying references, please be careful as they may already contain errors. Use of the DOI 
is encouraged.  
 
A DOI can be used to cite and link to electronic articles where an article is in-press and 
full citation details are not yet known, but the article is available online. A DOI is 
guaranteed never to change, so you can use it as a permanent link to any electronic 
article. An example of a citation using DOI for an article not yet in an issue is: VanDecar 
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J.C., Russo R.M., James D.E., Ambeh W.B., Franke M. (2003). Aseismic continuation of the 
Lesser Antilles slab beneath northeastern Venezuela. Journal of Geophysical Research, 
https://doi.org/10.1029/2001JB000884. Please note the format of such citations 
should be in the same style as all other references in the paper.  
 
Web references  
As a minimum, the full URL should be given and the date when the reference was last 
accessed. Any further information, if known (DOI, author names, dates, reference to a 
source publication, etc.), should also be given. Web references can be listed separately 
(e.g., after the reference list) under a different heading if desired, or can be included in 
the reference list.  
 
Data references  
This journal encourages you to cite underlying or relevant datasets in your manuscript 
by citing them in your text and including a data reference in your Reference List. Data 
references should include the following elements: author name(s), dataset title, data 
repository, version (where available), year, and global persistent identifier. Add 
[dataset] immediately before the reference so we can properly identify it as a data 
reference. The [dataset] identifier will not appear in your published article.  
 
Reference management software  
Most Elsevier journals have their reference template available in many of the most 
popular reference management software products. These include all products that 
support Citation Style Language styles, such as Mendeley and Zotero, as well as 
EndNote. Using the word processor plug-ins from these products, authors only need to 
select the appropriate journal template when preparing their article, after which 
citations and bibliographies will be automatically formatted in the journal's style. If no 
template is yet available for this journal, please follow the format of the sample 
references and citations as shown in this Guide.  
 
Reference style 
Text: Indicate references by number(s) in square brackets in line with the text. The 
actual authors can be referred to, but the reference number(s) must always be given. 
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List: Number the references (numbers in square brackets) in the list in the order in 
which they appear in the text. 
Examples: 
Reference to a journal publication: 
[1] Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci 
Commun 2010;163:51–9. 
Reference to a book: 
[2] Strunk Jr W, White EB. The elements of style. 4th ed. New York: Longman; 2000. 
Reference to a chapter in an edited book: 
[3] Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones 
BS, Smith RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc; 
2009, p. 281–304. Reference to a website: 
[4] Cancer Research UK. Cancer statistics reports for the UK, 
http://www.cancerresearchuk.org/ aboutcancer/statistics/cancerstatsreport/; 2003 
[accessed 13.03.03]. 
Note shortened form for last page number. e.g., 51–9, and that for more than 6 authors 
the first 6 should be listed followed by 'et al.' For further details you are referred to 
'Uniform Requirements for Manuscripts submitted to Biomedical Journals' (J Am Med 
Assoc 1997;277:927–34) (see also Samples of Formatted References).  
 
RESEARCH DATA  
This journal encourages and enables you to share data that supports your research 
publication where appropriate, and enables you to interlink the data with your 
published articles. Research data refers to the results of observations or 
experimentation that validate research findings. To facilitate reproducibility and data 
reuse, this journal also encourages you to share your software, code, models, 
algorithms, protocols, methods and other useful materials related to the project.  
 
Below are a number of ways in which you can associate data with your article or make a 
statement about the availability of your data when submitting your manuscript. If you 
are sharing data in one of these ways, you are encouraged to cite the data in your 
manuscript and reference list. Please refer to the "References" section for more 
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information about data citation. For more information on depositing, sharing and using 
research data and other relevant research materials, visit the research data page.  
 
Data linking  
If you have made your research data available in a data repository, you can link your 
article directly to the dataset. Elsevier collaborates with a number of repositories to link 
articles on ScienceDirect with relevant repositories, giving readers access to underlying 
data that gives them a better understanding of the research described.  
 
There are different ways to link your datasets to your article. When available, you can 
directly link your dataset to your article by providing the relevant information in the 
submission system. For more information, visit the database linking page.  
For supported data repositories a repository banner will automatically appear next to 
your published article on ScienceDirect.  
 
In addition, you can link to relevant data or entities through identifiers within the text of 
your manuscript, using the following format: Database: xxxx (e.g., TAIR: AT1G01020; 
CCDC: 734053; PDB: 1XFN).  
 
Mendeley Data  
This journal supports Mendeley Data, enabling you to deposit any research data 
(including raw and processed data, video, code, software, algorithms, protocols, and 
methods) associated with your manuscript in a free-to-use, open access repository. 
During the submission process, after uploading your manuscript, you will have the 
opportunity to upload your relevant datasets directly to Mendeley Data. The datasets 
will be listed and directly accessible to readers next to your published article online.  
For more information, visit the Mendeley Data for journals page.  
 
Data statement  
To foster transparency, we encourage you to state the availability of your data in your 
submission. This may be a requirement of your funding body or institution. If your data 
is unavailable to access or unsuitable to post, you will have the opportunity to indicate 
why during the submission process, for example by stating that the research data is 
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confidential. The statement will appear with your published article on ScienceDirect. 
For more information, visit the Data Statement page.  
 
AudioSlides  
The journal encourages authors to create an AudioSlides presentation with their 
published article. AudioSlides are brief, webinar-style presentations that are shown 
next to the online article on ScienceDirect. This gives authors the opportunity to 
summarize their research in their own words and to help readers understand what the 
paper is about. More information and examples are available. Authors of this journal 
will automatically receive an invitation e-mail to create an AudioSlides presentation 
after acceptance of their paper.  
 
Interactive Case Insights  
The journal encourages authors to complement their case reports with test questions 
that reinforce the key learning points. These author created questions are submitted 
along with the article ( new or revised ) and will be made available in ScienceDirect 
along with your paper. More information and examples are available at 
http://www.elsevier.com/about/content-innovation/interactive-case-insights. Test 
questions are created online at http://elsevier-
apps.sciverse.com/GadgetICRWeb/verification. Create the test questions, save them as 
a file to your desktop, and submit along with your (new or revised) manuscript through 
EES. For questions, please contact icihelp@elsevier.com Please check the manuscript 
carefully before it is sent off to the Editorial Office, both for correct content and 
typographical errors, as it is not possible to change the content of accepted typescripts 
during the production process. As a guide, please ensure the following had been 
included:  
• One copy of manuscript and; 
• Tables, figures and illustrations, uploaded separately and correctly labelled; 
• Reference list in correct style and correct in-text referencing; 
• Written permission from original publishers and authors to reproduce any borrowed 
any borrowed material (where relevant).  
 
Statistics  
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Statistics - Standard methods of presenting statistical material should be used. Where 
methods used are not widely recognised explanation and full reference to widely 
accessible sources must be given.  
 
REVISED SUBMISSIONS  
At revision stage the following documentation is required: 
• a separate "Response to Reviewers" file – Responses to the reviewers' and editors' 
comments.  
• a revised blinded manuscript with changes clearly highlighted.  
 
Revised submissions should be accompanied by a letter which responds point by point 
to the reviewers' and editors' comments, and changes to the revised paper should be 
highlighted so they can be spotted easily by the reviewers to whom the paper is 
normally returned for further review/comment. 22010  
 
Use of word processing software  
Regardless of the file format of the original submission, at revision you must provide us 
with an editable file of the entire article. Keep the layout of the text as simple as 
possible. Most formatting codes will be removed and replaced on processing the article. 
The electronic text should be prepared in a way very similar to that of conventional 
manuscripts (see also the Guide to Publishing with Elsevier: 
http://www.elsevier.com/guidepublication). See also the section on Electronic artwork.  
 
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 
'grammar-check' functions of your word processor.  
 
AFTER ACCEPTANCE  
Online proof correction  
Corresponding authors will receive an e-mail with a link to our online proofing system, 
allowing annotation and correction of proofs online. The environment is similar to MS 
Word: in addition to editing text, you can also comment on figures/tables and answer 
questions from the Copy Editor. Web-based proofing provides a faster and less error-
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prone process by allowing you to directly type your corrections, eliminating the 
potential introduction of errors.  
 
If preferred, you can still choose to annotate and upload your edits on the PDF version. 
All instructions for proofing will be given in the e-mail we send to authors, including 
alternative methods to the online version and PDF. 
 
We will do everything possible to get your article published quickly and accurately. 
Please use this proof only for checking the typesetting, editing, completeness and 
correctness of the text, tables and figures. Significant changes to the article as accepted 
for publication will only be considered at this stage with permission from the Editor. It 
is important to ensure that all corrections are sent back to us in one communication. 
Please check carefully before replying, as inclusion of any subsequent corrections 
cannot be guaranteed. Proofreading is solely your responsibility.  
 
Offprints  
The corresponding author will, at no cost, receive a customized Share Link providing 50 
days free access to the final published version of the article on ScienceDirect. The Share 
Link can be used for sharing the article via any communication channel, including email 
and social media. For an extra charge, paper offprints can be ordered via the offprint 
order form which is sent once the article is accepted for publication. Both 
corresponding and co-authors may order offprints at any time via Elsevier's Webshop. 
Corresponding authors who have published their article open access do not receive a 
Share Link as their final published version of the article is available open access on 
ScienceDirect and can be shared through the article DOI link.  
 
AUTHOR INQUIRIES  
Visit the Elsevier Support Center to find the answers you need. Here you will find 
everything from Frequently Asked Questions to ways to get in touch. 
You can also check the status of your submitted article or find out when your accepted 
article will be published.  

